US8460257B2 - Reduced-pressure, wound-treatment dressings and systems - Google Patents

Reduced-pressure, wound-treatment dressings and systems Download PDF

Info

Publication number
US8460257B2
US8460257B2 US12/610,910 US61091009A US8460257B2 US 8460257 B2 US8460257 B2 US 8460257B2 US 61091009 A US61091009 A US 61091009A US 8460257 B2 US8460257 B2 US 8460257B2
Authority
US
United States
Prior art keywords
wound
contracting
pressure
reduced
contracting element
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US12/610,910
Other versions
US20100121286A1 (en
Inventor
Christopher Brian Locke
Timothy Mark Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solventum Intellectual Properties Co
Original Assignee
KCI Licensing Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US12/610,910 priority Critical patent/US8460257B2/en
Application filed by KCI Licensing Inc filed Critical KCI Licensing Inc
Publication of US20100121286A1 publication Critical patent/US20100121286A1/en
Priority to US13/894,217 priority patent/US10398603B2/en
Application granted granted Critical
Publication of US8460257B2 publication Critical patent/US8460257B2/en
Assigned to KCI LICENSING, INC. reassignment KCI LICENSING, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ROBINSON, TIMOTHY MARK, LOCKE, CHRISTOPHER BRIAN
Assigned to WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT reassignment WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT SECOND LIEN SECURITY AGREEMENT Assignors: KCI LICENSING, INC., KCI USA, INC., LIFECELL CORPORATION
Assigned to WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT reassignment WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Assignors: KCI LICENSING, INC., KCI USA, INC., LIFECELL CORPORATION
Assigned to KCI USA, INC. reassignment KCI USA, INC. RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Assignors: WILMINGTON TRUST
Priority to US16/445,921 priority patent/US20190298577A1/en
Assigned to KCI LICENSING, INC., KCI USA, INC. reassignment KCI LICENSING, INC. RELEASE OF SECURITY INTEREST IN PATENTS Assignors: WILMINGTON TRUST, NATIONAL ASSOCIATION
Assigned to 3M INNOVATIVE PROPERTIES COMPANY reassignment 3M INNOVATIVE PROPERTIES COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KCI LICENSING, INC.
Assigned to SOLVENTUM INTELLECTUAL PROPERTIES COMPANY reassignment SOLVENTUM INTELLECTUAL PROPERTIES COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: 3M INNOVATIVE PROPERTIES COMPANY
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/91Suction aspects of the dressing
    • A61M1/915Constructional details of the pressure distribution manifold
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/08Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
    • A61B17/085Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound with adhesive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/00987Apparatus or processes for manufacturing non-adhesive dressings or bandages
    • A61F13/05
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00526Methods of manufacturing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00884Material properties enhancing wound closure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00889Material properties antimicrobial, disinfectant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00893Material properties pharmaceutically effective
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/08Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
    • A61B17/085Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound with adhesive layer
    • A61B2017/086Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound with adhesive layer having flexible threads, filaments, laces or wires, e.g. parallel threads, extending laterally from a strip, e.g. for tying to opposing threads extending from a similar strip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3417Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
    • A61B17/3421Cannulas
    • A61B2017/345Cannulas for introduction into a natural body opening
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/91Suction aspects of the dressing
    • A61M1/916Suction aspects of the dressing specially adapted for deep wounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/92Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with liquid supply means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0266Shape memory materials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/49Method of mechanical manufacture
    • Y10T29/49826Assembling or joining

Definitions

  • the present invention relates generally to medical treatment systems, and more particularly, to a reduced-pressure, wound-treatment dressings, systems, and methods.
  • Wounds may be received either intentionally, such as surgical incisions, or unintentionally, such as in an accident. In either case, closure of the wound is important to prevent loss of vital body fluids and invasion by micro-organisms. Wounds are typically closed through the use of sutures or staples.
  • sutures or staples may, however, have undesirable side-effects.
  • the insertion of sutures or staples necessarily involves inflicting the patient with an additional wound where the sutures or staples enter the epidermis of the patient.
  • additional wounds are also subject to possible infection.
  • the wound itself may result in scarring
  • the additional wounds from the sutures or staples may also result in additional scarring, which may unnecessarily highlight the already atheistically undesirable nature of the original wound scar.
  • a reduced-pressure, wound-treatment system for treating a wound on a patient includes a wound-closing dressing, a manifold member for disposing between a tissue-facing surface of a sealing drape and the wound; and a reduced-pressure subsystem for delivering a reduced pressure to the wound-closing dressing.
  • the wound-closing dressing includes the sealing drape having a first surface and a tissue-facing surface, a contracting element coupled to the sealing drape, and a gripping member coupled to the sealing drape.
  • the sealing drape is for placing over the wound.
  • the contracting element is configured to contract when activated and to thereby generate a closing force.
  • the gripping member is configured to transmit the closing force to a patient's epidermis.
  • the sealing drape and gripping member are configured to form a fluid seal over the wound.
  • a wound-closing dressing includes a sealing drape having a first surface and a tissue-facing surface, a contracting element coupled to the sealing drape, and a gripping member coupled to the sealing drape.
  • the sealing drape is for placing over the wound.
  • the contracting element is configured to contract when activated and to thereby generate a closing force.
  • the gripping member is configured to transmit the closing force to a patient's epidermis.
  • the sealing drape and gripping member are configured to form a fluid seal over the wound.
  • a wound-closing dressing includes a sealing drape having a first surface and a tissue-facing surface, a dissolvable body coupled to the sealing drape, and an elastic member coupled to the dissolvable body in a stretched position.
  • the sealing drape is for placing over a wound.
  • the elastic member contracts to a free position when at least a portion of the dissolvable body dissolves thereby generating a closing force.
  • the wound-closing dressing further includes a gripping member coupled to at least one of the sealing drape and elastic member. The gripping member is configured to transmit the closing force to a patient's epidermis.
  • a method for treating a wound includes the steps of securing a contracting element to a patient's epidermis such that the contracting element spans at least a portion of the patient's wound and activating the contracting element such that the contracting element generates a closing force.
  • the contracting element is configured to contract from an extended position to a contracted position and thereby generates the closing force when activated.
  • a method of manufacturing a wound closing dressing includes the steps of forming a sealing drape having a first surface and a tissue-facing surface, coupling a contracting element to the sealing drape, and coupling a gripping member to the sealing drape.
  • the gripping member is configured to transmit the closing force to a patient's epidermis.
  • the contracting element is configured to contract from an extended position to a contracted position and thereby generates a closing force when activated.
  • FIG. 1 is a schematic, perspective view of an illustrative, non-limiting embodiment of a system for treating a wound on a patient;
  • FIG. 2 is a schematic, cross-sectional view of the system of FIG. 1 taken along line 2 - 2 in FIG. 1 ;
  • FIG. 3A is a schematic, top view of the system of FIG. 1 ;
  • FIG. 3B is a schematic, top view of the system of FIG. 1 showing several contracting elements activated thereby generating a closing force;
  • FIG. 4A is a schematic, top view of an illustrative, non-limiting embodiment of a wound-closing dressing shown over a wound;
  • FIG. 4B is a schematic, top view of the dressing of FIG. 4A showing the contracting element activated thereby generating a closing force;
  • FIG. 5 is a schematic, top view of an illustrative, non-limiting embodiment of a system for treating a wound
  • FIG. 6 is a schematic, top view of an illustrative, non-limiting embodiment of a system for treating a wound shown;
  • FIG. 7A is a schematic, bottom view of a portion of an illustrative, non-limiting embodiment of a system for treating a wound
  • FIG. 7B is a schematic, perspective view of the system of FIG. 7A ;
  • FIG. 8 is a schematic, perspective view of a portion of an illustrative, non-limiting embodiment of a system for treating a wound
  • FIG. 9A is a schematic, top view of the system portion of FIG. 8 ;
  • FIG. 9B is a schematic, top view of the system portion of FIG. 8 showing several beads dissolved whereby the corresponding elastic members generate a closing force.
  • the reduced-pressure, wound-treatment system 100 generally includes a wound-closing dressing 110 , a manifold member 112 , and a reduced-pressure subsystem 114 .
  • the reduced-pressure, wound-treatment system 100 is shown in a region around the wound 102 .
  • the wound 102 is through epidermis 104 (or skin), dermis 106 , and reaches into a hypodermis, or subcutaneous tissue 108 .
  • the subcutaneous tissue 108 may include numerous tissue types, such as fatty tissue or muscle.
  • wound 102 in the illustrative embodiment is shown as reaching through the epidermis 104 , dermis 106 and into the subcutaneous tissue 108 , it will be appreciated that the reduced-pressure, wound-treatment system 100 may be used to treat a wound of any depth.
  • the wound-closing dressing 110 includes a sealing drape 116 , one or more contracting elements 118 , and a gripping member 120 .
  • the sealing drape 116 includes a first surface 122 and a second, tissue-facing surface 124 .
  • the sealing drape 116 may be sized so that the sealing drape 116 overlaps the wound 102 in such a manner that drape extensions 126 extend beyond a periphery of the wound 102 .
  • the sealing drape 116 may be an elastomeric material.
  • “Elastomeric” means having the properties of an elastomer. It generally refers to a polymeric material that has rubber-like properties. More specifically, most elastomers have elongation rates greater than 100% and a significant amount of resilience. The resilience of a material refers to the material's ability to recover from an elastic deformation.
  • elastomers may include, but are not limited to, natural rubbers, polyisoprene, styrene butadiene rubber, chloroprene rubber, polybutadiene, nitrile rubber, butyl rubber, ethylene propylene rubber, ethylene propylene diene monomer, chlorosulfonated polyethylene, polysulfide rubber, polyurethane, EVA film, co-polyester, and silicones.
  • sealing member materials include a silicone drape, 3M Tegaderm® drape, acrylic drape such as one available from Avery Dennison, or an incise drape material.
  • the sealing drape 116 may be formed from any suitable material.
  • the sealing drape 116 may be fenestrated to allow moisture or water vapor to pass through in order to activate the contracting elements (discussed further below). Unless otherwise indicated, as used herein, “or” does not require mutual exclusivity.
  • One or more contracting elements 118 are coupled to the sealing drape 116 .
  • Each contracting element 118 is configured to contract when activated in order to generate a closing force (such as in the direction illustrated by vectors or arrows 128 in FIG. 3B ) that may assist in closing the wound 102 .
  • the contracting elements 118 are in a stretched position when the wound-closing dressing 110 is applied to the patient.
  • the contracting elements 118 may be coupled to the sealing drape 116 in a stretched position or may be moved to a stretched position as the wound-closing dressing 110 is being applied to the patient. In either case, when the contracting elements 118 are activated, they seek to return to a non-stretched, or free position, and thereby contract to generate a closing force.
  • Other illustrative ways of contracting are described further below.
  • the wound-closing dressing 110 may include a variety of contracting elements 118 arranged in numerous configurations.
  • the wound-closing dressing 110 may include a plurality of contracting elements 118 that are each formed as a strip.
  • the wound-closing dressing 110 may include a single contracting element 118 .
  • one or more contracting elements 118 may be woven into the sealing drape 116 or woven into an additional member, such as gauze, another drape-like piece, etc., which is coupled to the sealing drape 116 .
  • each contracting element 118 may be coupled to the sealing drape 116 by any suitable device or technique, including, but not limited to, welding (e.g., ultrasonic or RF welding), bonding, mechanical fasteners, adhesives, cements, etc.
  • each contracting element 118 may be molded into the sealing drape 116 .
  • the contracting elements 118 are coupled to the second, tissue-facing surface 124 of the sealing drape 116 or to the first surface 122 of the sealing drape 116 or an internal portion of the sealing drape 116 .
  • Each contracting element 118 may be formed from any suitable material that contracts in response to being activated.
  • the contracting element 118 is configured to move from an extended position to a contracted position (or free position) upon full activation.
  • each contracting element 118 may be formed from cellulose whereby moisture causes the contracting element 118 to contract.
  • the moisture may be introduced from the patient's own exudate.
  • the moisture by way of a fluid, such as water, bacteriostatic water, saline, etc., may be introduced to the wound 102 or wound area prior to the wound-closing dressing 110 being applied to the patient.
  • the sealing drape 116 may be provided with a port (not shown) for introducing fluid to the wound area to activate the contracting elements 118 after the wound-closing dressing 110 has been applied to the patient.
  • the contracting elements 118 may be formed from a shape-memory metal that contracts in response to being activated.
  • a suitable shape-memory metal is Nitinol® material from Nitinol Devices & Components of Fremont, Calif.
  • the contracting elements 118 formed from a shape-memory metal may be activated by heat, such as a patient's body heat, warming pads, heat lamps, etc.
  • the contracting elements 118 may be activated by the introduction of electromagnetic induction.
  • the contracting elements 118 may be formed from any suitable material, including but not limited to shape memory alloys, magnetic shape memory alloys, shape memory polymers, piezoelectric materials, electroactive polymers, magnetorheological fluids and elastomers, and electrorheological fluids.
  • the activation may take the form of an electric field, a temperature change, a magnetic field, a mechanical loading or stressing, light, UV-light, changes in environmental pH, ultrasound, moisture, etc.
  • the gripping member 120 facilitates transmission of closing force (shown by arrows 128 ) generated by the contraction of the contracting elements 118 to the patient's skin.
  • the transmitted force is illustrated as force vectors 130 in FIG. 2 .
  • the sealing drape 116 and gripping member 120 can work together to form a fluid seal over the patient's wound 102 .
  • Fluid seal or “seal,” means a seal adequate to maintain reduced pressure at a desired site given the particular reduced-pressure source or subsystem involved.
  • the gripping member 120 may be any material suitable for transmitting the closing force from the contracting elements 118 to the patient's epidermis 104 (which may be deemed to include a gasket or other layer of material) or assist in forming a fluid seal over the wound 102 .
  • the gripping member 120 may be a pressure-sensitive adhesive, heat-activated adhesive, sealing tape, double-sided sealing tape, paste, hydrocolloid, hydrogel, hooks, sutures, etc.
  • the gripping member 120 is an adhesive layer and spans the width of the second, tissue-facing surface 124 of the sealing drape 116 and overlays the contracting elements 118 .
  • the gripping member 120 may merely be coupled to tissue-facing surfaces of the drape extensions 126 .
  • the gripping member 120 may be formed as a laminar layer or a pattern distributed on the sealing drape 116 .
  • the gripping member 120 may be applied over the entire first surface 122 of the sealing drape 116 , or over the first surfaces of the drape extensions 126 .
  • a manifold member 112 is positionable between the second, tissue-facing surface 124 of the sealing drape 116 and at least a portion of the wound 102 .
  • the manifold member 112 may be sized to substantially cover the estimated area of the wound 102 , although a larger or smaller size may be used in different applications.
  • the manifold member 112 is made from a manifold material.
  • manifold generally refers to a substance or structure that is provided to assist in applying reduced pressure to, delivering fluids to, or removing fluids from the wound 102 .
  • the manifold member 112 typically includes a plurality of flow channels or pathways that distribute fluids provided to and removed from the wound 102 around the manifold member 112 .
  • the flow channels or pathways are interconnected to improve distribution of fluids provided or removed from the wound 102 .
  • the manifold member 112 may be a biocompatible material that is capable of being placed in contact with wound 102 and distributing reduced pressure to the wound 102 .
  • manifold members 112 may include, for example, without limitation, devices that have structural elements arranged to form flow channels, such as, for example, cellular foam, open-cell foam, porous tissue collections, liquids, gels, and foams that include, or cure to include, flow channels.
  • the manifold member 112 may be porous and may be made from foam, gauze, felted mat, or any other material suited to a particular biological application.
  • the manifold member 112 is a porous foam and includes a plurality of interconnected cells or pores that act as flow channels.
  • the porous foam may be a polyurethane, open-cell, reticulated foam, such as GranuFoam® material manufactured by Kinetic Concepts, Incorporated of San Antonio, Tex. Other embodiments may include “closed cells.”
  • the manifold member 112 may also be used to distribute fluids, such as medications, antibacterials, growth factors, and various solutions to the wound 102 .
  • Other layers may be included in or on the manifold member 112 , such as absorptive materials, wicking materials, hydrophobic materials, and hydrophilic materials.
  • the manifold member 112 may be isotropic or anisotropic depending on the exact orientation of the compressive forces that are desired during reduced pressure.
  • the manifold material may be a bio-absorbable material.
  • the manifold member 112 may be coupled to the sealing drape 116 .
  • the coupling may occur in many ways.
  • the sealing drape 116 and manifold member 112 may be coupled using adhesives such as an acrylic adhesive, silicone adhesive, hydrogel, hydrocolloid, etc.
  • the sealing drape 116 and manifold member 112 may be bonded by heat bonding, ultrasonic bonding, and radio frequency bonding, etc.
  • the coupling may occur in patterns or more completely. Structure might be added to the bond to make the sealing drape 116 behave anisotropically in a desired direction, i.e., to make an anisotropic drape material.
  • An anisotropic drape material may work in conjunction with the contracting elements 118 to primarily move in a given direction, i.e., only about a certain axis or axes.
  • an anisotropic sealing drape may work in conjunction with the contracting elements to generate a closing force to assist in closing a wound.
  • the reduced-pressure subsystem 114 includes a reduced-pressure source 132 , which can take many different forms.
  • the reduced-pressure source 132 provides a reduced pressure as a part of the reduced-pressure, wound-treatment system 100 .
  • the reduced-pressure source 132 provides reduced pressure.
  • the reduced-pressure source 132 may be any device for supplying a reduced pressure, such as a vacuum pump, wall suction, or other source. While the amount and nature of reduced pressure applied to a tissue site or wound will typically vary according to the application, the reduced pressure will typically be between ⁇ 5 mm Hg and ⁇ 500 mm Hg and more typically between ⁇ 100 mm Hg and ⁇ 300 mm Hg, and still more typically in the range ⁇ 100 mm Hg and ⁇ 200 mm Hg.
  • reduced pressure generally refers to a pressure less than the ambient pressure at a tissue site or wound that is being subjected to treatment. In most cases, this reduced pressure will be less than the atmospheric pressure at which the patient is located. Alternatively, the reduced pressure may be less than a hydrostatic pressure at the tissue site. Unless otherwise indicated, values of pressure stated herein are gauge pressures.
  • the reduced pressure delivered may be constant or varied (patterned or random) and may be delivered continuously or intermittently.
  • vacuum and negative pressure may be used to describe the pressure applied to the tissue site, the actual pressure applied to the tissue site may be more than the pressure normally associated with a complete vacuum. Consistent with the use herein, an increase in reduced pressure or vacuum pressure typically refers to a relative reduction in absolute pressure.
  • the reduced-pressure source 132 is shown having a battery compartment 134 and a canister region 136 with windows 138 providing a visual indication of the level of fluid within the canister 136 .
  • An interposed membrane filter such as hydrophobic or oleophobic filter, may be interspersed between a reduced-pressure delivery conduit, or tubing, 140 and the reduced-pressure source 132 .
  • the reduced pressure developed by the reduced-pressure source 132 is delivered through the reduced-pressure delivery conduit 140 to a reduced-pressure interface 142 , which may be an elbow port 144 .
  • the elbow port 144 is a TRAC® technology port available from KCl of San Antonio, Tex.
  • the reduced-pressure interface 142 allows the reduced pressure to be delivered to the wound-closing dressing 110 and realized within an interior portion of wound-closing dressing 110 as well as the manifold member 112 .
  • the elbow port 144 extends through the sealing drape 116 to the manifold member 112 .
  • One or more devices 141 may be added to the reduced-pressure delivery conduit 140 .
  • the device 141 may be a fluid reservoir, or collection member, to hold exudates and other fluids removed.
  • Other examples of devices 141 that may be included on the reduced-pressure delivery conduit 140 or otherwise fluidly coupled to the reduced-pressure delivery conduit 140 include the following non-limiting examples: a pressure-feedback device, a volume detection system, a blood detection system, an infection detection system, a flow monitoring system, a temperature monitoring system, etc. Some of these devices may be formed integral to the reduced-pressure source 132 .
  • the reduced-pressure, wound-treatment system 100 may be applied to the wound 102 of the patient.
  • the manifold member 112 is first placed over the wound 102 .
  • the manifold member 112 may be placed within the wound 102 or may overlay a portion of the wound 102 . If the wound-closing dressing 110 has not been coupled to the manifold member 112 , the wound-closing dressing 110 may then be placed over the top of the manifold member 112 such that drape extensions 126 of the sealing drape 116 extend beyond the periphery of the wound 102 .
  • the drape extensions 126 are secured to the patient's epidermis 104 by the gripping member 120 in order to form a fluid seal over the wound 102 .
  • the one or more contracting elements 118 may then be activated such that the contracting elements 118 generate a contracting force (shown by arrows 128 ) that is transmitted to the patient's epidermis 104 via the gripping member 120 so that wound edges 101 are drawn closer together.
  • a contracting force shown by arrows 128
  • the reduced-pressure interface 142 is applied, if not already installed, and the reduced-pressure delivery conduit 140 fluidly coupled at one end.
  • the other end of the reduced-pressure delivery conduit 140 is fluidly coupled to the reduced-pressure source 132 .
  • the reduced-pressure source 132 may then be activated such that reduced pressure is delivered to the wound-closing dressing 110 .
  • application of reduced pressure may, in part, serve to draw the extra fluid out from the interior of the wound-closing dressing 110 and onto the contracting elements 118 .
  • the manifold member 112 compresses and contracts laterally to form a semi-rigid substrate.
  • the reduced pressure is transmitted further still through the manifold member 112 so that the reduced pressure is experienced at the patient's epidermis 104 and at the wound 102 .
  • the reduced pressure delivered to the manifold member 112 may develop a compressive force 146 that may provide stability and therapy.
  • the compressive force 146 may be more than just at the top of the epidermis 104 ; the compressive force 146 may extend down deeper and may be experienced at the level of subcutaneous tissue 108 .
  • an inward force 148 may develop that may help hold an additional closing force on the wound 102 and may generally provide additional stability to the wound 102 .
  • the inward force 148 from the reduced pressure and the force 130 from the contracting elements 118 may act together to assist in closing the wound 102 .
  • the reduced pressure delivered to and through the manifold member 112 helps to remove any exudates and other fluids from the wound 102 and provides reduced pressure therapy to the wound 102 . All of these actions may improve healing of the wound 102 .
  • FIG. 3A the wound-closing dressing 110 is shown deployed on a wound 102 before the activation of the contracting elements 118 .
  • FIG. 3B shows the wound-closing dressing 110 after at least the three most inboard contracting elements 118 have contracted at least in part to provide a closing force as suggested by arrows 128 .
  • the reduced-pressure, wound-treatment system 100 may be applied in the operating room and allow the reduced-pressure, wound-treatment system 100 to remain on the patient until adequate healing has taken place.
  • the reduced-pressure, wound-treatment system 100 may be used as a primary wound-closing treatment or as an intermediate step of a wound-closing treatment.
  • the wound-closing dressing 110 may be used without the manifold member 112 or reduced-pressure subsystem 114 .
  • the wound-closing dressing 110 may be beneficial as a stand-alone bandage that is capable of delivering a closing force to a wound 102 without requiring reduced pressure.
  • FIGS. 4A and 4B an illustrative embodiment of a wound-closing dressing 210 is shown.
  • the wound-closing dressing 210 is analogous in most respects to the wound-closing dressing 110 and related components of FIGS. 1-3B and a correlation of parts is generally indicated in this embodiment by indexing the numerals by 100.
  • sealing drape 216 is analogous to sealing drape 116 .
  • the wound-closing dressing 210 could be used as part of a reduced-pressure system, such as the reduced-pressure, wound-treatment system 100 .
  • the wound-closing dressing 210 may be shaped to approximate the shape of a wound 202 or extend beyond the wound 202 .
  • wound-closing dressing 210 may have any suitable plan view, including, but not limited to, square, rectangular, triangular, elliptical, hexagonal, octagonal, irregular, etc.
  • the contracting elements 218 may be woven together in a “thatched” pattern such that, when activated, a substantially equal closing force (represented by arrows 228 in FIG. 4B ) may be distributed about an entire periphery 203 of the wound 202 .
  • FIG. 4A shows the wound-closing dressing 210 and wound 202 prior to activation of the contracting elements 218
  • FIG. 4B shows the wound-closing dressing 210 and wound 202 after the contracting elements 218 have been activated.
  • FIG. 5 another illustrative reduced-pressure, wound-closure system 300 for treating a wound 302 on a patient is shown.
  • the system is generally analogous in most respects to that of the reduced-pressure, wound-treatment system 100 of FIGS. 1-3B . Analogous parts are indicated by indexing the reference numerals of FIGS. 1-3B by 200.
  • a plurality of contracting elements 318 and backing strips 350 may be utilized. Each contracting element 318 and corresponding backing strip 350 form a contracting strip 352 .
  • a plurality of contracting strips 352 may be utilized.
  • Each contracting element 318 is releasably coupled to the corresponding backing strip 350 .
  • the contracting element 318 is configured to contract when activated in order to generate a closing force that may assist in closing the wound 302 .
  • the contracting elements 318 may be releasably coupled to the backing strip 350 in a stretched position or may be moved to a stretched position as the contracting strip 352 is applied to the patient. In either case, when the contracting element 318 is activated, the contracting element 318 seeks to return to a non-stretched position, or free position, and thereby contracts to generate a closing force.
  • each contracting strip 352 shows each contracting strip 352 as having a single contracting element 318
  • any suitable number of contracting elements 318 may be employed.
  • the contracting strip 352 includes a plurality of contracting elements 318
  • the plurality of contracting elements 318 may be arranged in any suitable pattern relative to one another, e.g., parallel, perpendicular, angled, etc.
  • a plurality of contracting elements 318 , backing strips 350 , and contracting strips 352 are mentioned, single members of each may be used as well.
  • the contracting element 318 may be formed from any suitable material that contracts in response to being activated and may be activated in numerous ways.
  • the backing strips 350 may be formed from any suitable material including, but not limited to, gauze, an elastomer, an adhesive, etc. Any suitable number of contracting strips 352 may be placed over the wound 302 and a manifold member, e.g., the manifold member 112 in FIG. 2 . Each contracting strip 352 may be secured to epidermis by corresponding gripping members in any suitable pattern to assist in closing the wound 302 .
  • a sealing drape 316 having a reduced-pressure interface 342 may be placed over the contracting strips 352 such that a reduced pressure may be delivered to the wound 302 ; alternatively or in addition, the contracting strips 352 may be placed atop the sealing drape 316 .
  • each contracting strip 352 employed may be formed from a drape material whereby each backing strip 350 works together with one or more adjacent backing strips 350 so as to form an unified drape thereby eliminating the need for an additional sealing drape; in this embodiment, it may be desirable to use a gripping member (e.g., an adhesive) having a high Moisture Vapor Transfer Rate (MVTR).
  • MVTR Moisture Vapor Transfer Rate
  • the contracting strips 352 may be used as stand-alone components (e.g., without the manifold and reduced pressure subsystem) to assist in closing a wound.
  • FIG. 6 another illustrative, non-limiting embodiment of a reduced-pressure, wound-closure system 400 for treating a wound 402 is presented.
  • the reduced-pressure, wound-closure system 400 is generally analogous in most respects to that of the reduced-pressure, wound-treatment system 100 of FIGS. 1-3B and analogous parts are indicated by indexing the reference numerals of FIG. 1-3B by 300.
  • Contracting elements 418 are arranged in a “star-shaped” pattern to deliver substantially equal closing forces to a periphery 401 of a wound 402 .
  • the contracting elements 418 include a central aperture 454 for receiving a reduced-pressure interface 442 therethrough. While the illustrative contracting elements 418 are shown as having eight “legs”, it will be appreciated that the contracting elements 418 may include any suitable number of legs and may be made as an integrated unit as shown or by a plurality of components.
  • FIG. 7A is a schematic bottom view of a portion of an illustrative embodiment of a system for treating a wound
  • FIG. 7B These figures include an alternative embodiment of a wound-closing dressing 500 for closing a wound.
  • the wound-closing dressing 500 includes a sealing drape 502 , a dissolvable body 504 , an elastic member 506 , and a gripping member 508 .
  • the wound-closing dressing 500 may be used as a stand-alone component to assist in wound closure or may be used as part of a reduced-pressure system to assist in wound closure and treatment.
  • the sealing drape 502 includes a first surface 510 and a second, tissue-facing surface 512 .
  • the sealing drape 502 generally may be formed from the same or similar materials to that of the sealing drape 116 of FIGS. 1-3B and may operate in a like manner.
  • the sealing drape 502 may be fenestrated to permit moisture to pass from the first surface 510 to the dissolvable body 504 .
  • the dissolvable body 504 is coupled to the second, tissue-facing surface 512 of the sealing drape 502 .
  • the dissolvable body 504 may be formed from any suitable dissolvable material, including, but not limited to, biodegradable or bioabsorbable materials, such as polylactide (PLA), poly(lactic-co-glycolic acid) (PLGA), polyglycolide (PGA), polycaprolactone (PCL), sodium chloride, or the like. Additionally, the dissolvable body 504 may include oxygenated particles or anti-microbial particles for reducing infection.
  • the dissolvable body 504 which holds the elastic member 506 in a stretched position, may dissolve under the influence of any suitable factor, including, but not limited to, moisture, heat, ultrasound, etc.
  • the elastic member 506 When the dissolvable body 504 dissolves, the elastic member 506 is, at least partially, released thereby generating a closing force as the elastic member 506 seeks to return to an unstretched position. While the illustrative embodiment shows a single dissolvable body 504 , it will be appreciated that any suitable number of dissolvable bodies may be employed (see e.g., FIGS. 8-9B ).
  • the elastic member 506 is coupled to the dissolvable body 504 in a stretched position such that when the dissolvable body 504 , or a portion thereof, dissolves, the elastic member 506 contracts to generate a closing force.
  • the elastic member 506 may be coupled to the dissolvable body 504 by any suitable device or technique, including, but not limited to adhesive, mechanical fasteners, bonding, sonic welding, etc. Alternatively or in addition, the elastic member 506 may be coupled by embedding the elastic member 506 in the dissolvable body 504 .
  • the elastic member 506 may be any suitable material that is capable of being coupled to the dissolvable body 504 in a stretched position and capable of contracting when at least a portion of the dissolvable body 504 dissolves.
  • the elastic member 506 may be formed from an elastomer.
  • the term “coupled” includes coupling via a separate object and includes direct coupling.
  • the term “coupled” also encompasses two or more components that are continuous with one another by virtue of each of the components being formed from the same piece of material.
  • the term “coupled” may include chemical, such as via a chemical bond, mechanical, thermal, or electrical coupling. Coupling may further include embedding one member in another.
  • the elastic member 506 in this illustrative embodiment has a substantially circular cross-section. It will be appreciated, however, that the elastic member 506 may have any suitable cross-section. Moreover, it will be appreciated that the elastic member 506 may have any suitable configuration. For example, the elastic member 506 may be arranged in a “thatched” pattern, a cross pattern, parallel pattern, etc. Also, while the illustrative embodiment shows a single elastic member 506 , it will be appreciated that any suitable number of elastic members 506 may be coupled to the dissolvable body 504 or bodies 504 . Also, the ends of the elastic member 506 may be coupled to the sealing drape 502 such that the contracting force generated by the elastic member 506 may be directly transferred to the gripping member 508 (as discussed further below).
  • the gripping member 508 is the same or similar to that of the gripping member 120 in the reduced-pressure, wound-treatment system 100 of FIGS. 1-3B .
  • the gripping member 508 may be coupled to at least one of the sealing drape 502 , dissolvable body 504 , or elastic member 506 .
  • the gripping member 508 is configured to transfer the force generated by the contracting of the elastic member 506 to the patient's epidermis to assist in closing a wound.
  • the wound-closing dressing 500 may also include a fenestrated sheet 514 that is disposed between the dissolvable body 504 and the wound in order to regulate the amount of moisture from the patient's exudate that is permitted to pass to the dissolvable body 504 . This may be useful to control the amount or rate that the dissolvable body 504 dissolves in instances where the dissolvable body 504 dissolves when moisture is introduced thereto.
  • a wound-closing dressing 610 for treating a wound 602 is shown.
  • the wound-closing dressing 610 is generally analogous in most respects to that of the wound-closing dressing 500 of FIGS. 7A and 7B . Analogous parts are indicated by indexing the reference numerals of FIGS. 7A and 7B by 100.
  • a dissolvable body 604 includes a plurality of dissolvable beads 618 or other dissolvable members.
  • the plurality of dissolvable beads 618 hold the force generated by a stretched elastic member 606 , and so as the plurality of dissolvable beads 618 are dissolved, an increasing force is experienced by a gripping member (not shown) that is attached to the elastic member 606 .
  • the beads 618 are typically dissolved by exudate from the wound 602 .
  • the generated closing force may have a direct relationship to the number of beads 618 that are dissolved. For example, as the number of beads 618 dissolved increases, the generated closing force may increase with a defined relationship, e.g., linearly, exponentially, etc.
  • the wound-closing dressing 610 may be “tuned” to generate a greater closing force at the wider portions of the wound 602 . Moreover, this may occur in a self-regulating way. In other words, areas of the wound 602 that have increased levels of exudate, typically the wider portions of the wound 602 , experience a greater closing force because the increased levels of exudate cause more beads 618 to dissolve which increases the closing force generated by the elastic member 606 .
  • the wound-closing dressing 610 may be used in conjunction with a sealing drape and gripping member similar to those of the wound-closing dressing 510 of FIGS. 7A and 7B and as part of a reduced-pressure treatment system. Alternatively, each end of each elastic member 606 may be secured to the patient's epidermis and the wound-closing dressing 610 used as a stand-alone dressing for assisting in wound closure.

Abstract

A wound-closing dressing, which is suitable for use as part of a reduced-pressure, wound-treatment system, may include a sealing drape, one or more contracting elements, and a gripping member. The contracting element may be coupled to the sealing drape and is configured to contract when activated and to generate a closing force. A gripping member is coupled to the sealing drape and is configured to transmit the closing force to a patient's epidermis. Other dressings, systems, and methods are also disclosed.

Description

RELATED APPLICATIONS
The present invention claims the benefit, under 35 U.S.C. §119(e), of the filing of U.S. Provisional Patent Application Ser. No. 61/112,371, entitled “Reduced-Pressure Wound Treatment Dressing and System,” filed 7 Nov. 2008, which is incorporated herein by reference for all purposes.
BACKGROUND
The present invention relates generally to medical treatment systems, and more particularly, to a reduced-pressure, wound-treatment dressings, systems, and methods.
Wounds may be received either intentionally, such as surgical incisions, or unintentionally, such as in an accident. In either case, closure of the wound is important to prevent loss of vital body fluids and invasion by micro-organisms. Wounds are typically closed through the use of sutures or staples.
The use of sutures or staples may, however, have undesirable side-effects. For example, the insertion of sutures or staples necessarily involves inflicting the patient with an additional wound where the sutures or staples enter the epidermis of the patient. These additional wounds are also subject to possible infection. Moreover, while the wound itself may result in scarring, the additional wounds from the sutures or staples may also result in additional scarring, which may unnecessarily highlight the already atheistically undesirable nature of the original wound scar.
BRIEF SUMMARY
Shortcomings with wound care are addressed by the present invention as shown and described in a variety of illustrative, non-limiting embodiments herein. According to an illustrative, non-limiting embodiment, a reduced-pressure, wound-treatment system for treating a wound on a patient includes a wound-closing dressing, a manifold member for disposing between a tissue-facing surface of a sealing drape and the wound; and a reduced-pressure subsystem for delivering a reduced pressure to the wound-closing dressing. The wound-closing dressing includes the sealing drape having a first surface and a tissue-facing surface, a contracting element coupled to the sealing drape, and a gripping member coupled to the sealing drape. The sealing drape is for placing over the wound. The contracting element is configured to contract when activated and to thereby generate a closing force. The gripping member is configured to transmit the closing force to a patient's epidermis. The sealing drape and gripping member are configured to form a fluid seal over the wound.
According to another illustrative, non-limiting embodiment, a wound-closing dressing includes a sealing drape having a first surface and a tissue-facing surface, a contracting element coupled to the sealing drape, and a gripping member coupled to the sealing drape. The sealing drape is for placing over the wound. The contracting element is configured to contract when activated and to thereby generate a closing force. The gripping member is configured to transmit the closing force to a patient's epidermis. The sealing drape and gripping member are configured to form a fluid seal over the wound.
According to another illustrative, non-limiting embodiment, a wound-closing dressing includes a sealing drape having a first surface and a tissue-facing surface, a dissolvable body coupled to the sealing drape, and an elastic member coupled to the dissolvable body in a stretched position. The sealing drape is for placing over a wound. The elastic member contracts to a free position when at least a portion of the dissolvable body dissolves thereby generating a closing force. The wound-closing dressing further includes a gripping member coupled to at least one of the sealing drape and elastic member. The gripping member is configured to transmit the closing force to a patient's epidermis.
According to another illustrative, non-limiting embodiment, a method for treating a wound includes the steps of securing a contracting element to a patient's epidermis such that the contracting element spans at least a portion of the patient's wound and activating the contracting element such that the contracting element generates a closing force. The contracting element is configured to contract from an extended position to a contracted position and thereby generates the closing force when activated.
According to another illustrative, non-limiting embodiment, a method of manufacturing a wound closing dressing includes the steps of forming a sealing drape having a first surface and a tissue-facing surface, coupling a contracting element to the sealing drape, and coupling a gripping member to the sealing drape. The gripping member is configured to transmit the closing force to a patient's epidermis. The contracting element is configured to contract from an extended position to a contracted position and thereby generates a closing force when activated.
BRIEF DESCRIPTION OF THE DRAWINGS
A more complete understanding of the present invention may be obtained by reference to the following Detailed Description when taken in conjunction with the accompanying Drawings wherein:
FIG. 1 is a schematic, perspective view of an illustrative, non-limiting embodiment of a system for treating a wound on a patient;
FIG. 2 is a schematic, cross-sectional view of the system of FIG. 1 taken along line 2-2 in FIG. 1;
FIG. 3A is a schematic, top view of the system of FIG. 1;
FIG. 3B is a schematic, top view of the system of FIG. 1 showing several contracting elements activated thereby generating a closing force;
FIG. 4A is a schematic, top view of an illustrative, non-limiting embodiment of a wound-closing dressing shown over a wound;
FIG. 4B is a schematic, top view of the dressing of FIG. 4A showing the contracting element activated thereby generating a closing force;
FIG. 5 is a schematic, top view of an illustrative, non-limiting embodiment of a system for treating a wound;
FIG. 6 is a schematic, top view of an illustrative, non-limiting embodiment of a system for treating a wound shown;
FIG. 7A is a schematic, bottom view of a portion of an illustrative, non-limiting embodiment of a system for treating a wound;
FIG. 7B is a schematic, perspective view of the system of FIG. 7A;
FIG. 8 is a schematic, perspective view of a portion of an illustrative, non-limiting embodiment of a system for treating a wound;
FIG. 9A is a schematic, top view of the system portion of FIG. 8; and
FIG. 9B is a schematic, top view of the system portion of FIG. 8 showing several beads dissolved whereby the corresponding elastic members generate a closing force.
DETAILED DESCRIPTION
In the following detailed description of the preferred embodiments, reference is made to the accompanying drawings that form a part hereof, and in which is shown, by way of illustration, specific embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is understood that other embodiments may be utilized and that logical structural, mechanical, electrical, and chemical changes may be made without departing from the spirit or scope of the invention. To avoid detail not necessary to enable those skilled in the art to practice the invention, the description may omit certain information known to those skilled in the art. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the present invention is defined only by the appended claims.
Referring now primarily to FIGS. 1-3B, a first illustrative, non-limiting embodiment of a reduced-pressure, wound-treatment system 100 for treating a wound 102 on a patient is shown. The reduced-pressure, wound-treatment system 100 generally includes a wound-closing dressing 110, a manifold member 112, and a reduced-pressure subsystem 114. The reduced-pressure, wound-treatment system 100 is shown in a region around the wound 102. In this illustration, the wound 102 is through epidermis 104 (or skin), dermis 106, and reaches into a hypodermis, or subcutaneous tissue 108. The subcutaneous tissue 108 may include numerous tissue types, such as fatty tissue or muscle. While the wound 102 in the illustrative embodiment is shown as reaching through the epidermis 104, dermis 106 and into the subcutaneous tissue 108, it will be appreciated that the reduced-pressure, wound-treatment system 100 may be used to treat a wound of any depth.
The wound-closing dressing 110 includes a sealing drape 116, one or more contracting elements 118, and a gripping member 120. The sealing drape 116 includes a first surface 122 and a second, tissue-facing surface 124. The sealing drape 116 may be sized so that the sealing drape 116 overlaps the wound 102 in such a manner that drape extensions 126 extend beyond a periphery of the wound 102.
The sealing drape 116 may be an elastomeric material. “Elastomeric” means having the properties of an elastomer. It generally refers to a polymeric material that has rubber-like properties. More specifically, most elastomers have elongation rates greater than 100% and a significant amount of resilience. The resilience of a material refers to the material's ability to recover from an elastic deformation. Examples of elastomers may include, but are not limited to, natural rubbers, polyisoprene, styrene butadiene rubber, chloroprene rubber, polybutadiene, nitrile rubber, butyl rubber, ethylene propylene rubber, ethylene propylene diene monomer, chlorosulfonated polyethylene, polysulfide rubber, polyurethane, EVA film, co-polyester, and silicones. Additional, specific examples of sealing member materials include a silicone drape, 3M Tegaderm® drape, acrylic drape such as one available from Avery Dennison, or an incise drape material. However, it will be appreciated that the sealing drape 116 may be formed from any suitable material. In one alternative, the sealing drape 116 may be fenestrated to allow moisture or water vapor to pass through in order to activate the contracting elements (discussed further below). Unless otherwise indicated, as used herein, “or” does not require mutual exclusivity.
One or more contracting elements 118 are coupled to the sealing drape 116. Each contracting element 118 is configured to contract when activated in order to generate a closing force (such as in the direction illustrated by vectors or arrows 128 in FIG. 3B) that may assist in closing the wound 102. In the illustrative embodiment, the contracting elements 118 are in a stretched position when the wound-closing dressing 110 is applied to the patient. The contracting elements 118 may be coupled to the sealing drape 116 in a stretched position or may be moved to a stretched position as the wound-closing dressing 110 is being applied to the patient. In either case, when the contracting elements 118 are activated, they seek to return to a non-stretched, or free position, and thereby contract to generate a closing force. Other illustrative ways of contracting are described further below.
The wound-closing dressing 110 may include a variety of contracting elements 118 arranged in numerous configurations. For example, as shown in FIGS. 1-3B, the wound-closing dressing 110 may include a plurality of contracting elements 118 that are each formed as a strip. Alternatively, the wound-closing dressing 110 may include a single contracting element 118. In yet another embodiment, one or more contracting elements 118 may be woven into the sealing drape 116 or woven into an additional member, such as gauze, another drape-like piece, etc., which is coupled to the sealing drape 116. Additionally, each contracting element 118 may be coupled to the sealing drape 116 by any suitable device or technique, including, but not limited to, welding (e.g., ultrasonic or RF welding), bonding, mechanical fasteners, adhesives, cements, etc. Alternatively, each contracting element 118 may be molded into the sealing drape 116. The contracting elements 118 are coupled to the second, tissue-facing surface 124 of the sealing drape 116 or to the first surface 122 of the sealing drape 116 or an internal portion of the sealing drape 116.
Each contracting element 118 may be formed from any suitable material that contracts in response to being activated. The contracting element 118 is configured to move from an extended position to a contracted position (or free position) upon full activation. For example, each contracting element 118 may be formed from cellulose whereby moisture causes the contracting element 118 to contract. The moisture may be introduced from the patient's own exudate. Alternatively or in addition, the moisture, by way of a fluid, such as water, bacteriostatic water, saline, etc., may be introduced to the wound 102 or wound area prior to the wound-closing dressing 110 being applied to the patient. In yet another alternative or addition, the sealing drape 116 may be provided with a port (not shown) for introducing fluid to the wound area to activate the contracting elements 118 after the wound-closing dressing 110 has been applied to the patient.
In another alternative or addition, the contracting elements 118 may be formed from a shape-memory metal that contracts in response to being activated. One example of a suitable shape-memory metal is Nitinol® material from Nitinol Devices & Components of Fremont, Calif. The contracting elements 118 formed from a shape-memory metal may be activated by heat, such as a patient's body heat, warming pads, heat lamps, etc. Alternatively or in addition, the contracting elements 118 may be activated by the introduction of electromagnetic induction. It will, however, be appreciated that the contracting elements 118 may be formed from any suitable material, including but not limited to shape memory alloys, magnetic shape memory alloys, shape memory polymers, piezoelectric materials, electroactive polymers, magnetorheological fluids and elastomers, and electrorheological fluids. Depending on the particular material, the activation may take the form of an electric field, a temperature change, a magnetic field, a mechanical loading or stressing, light, UV-light, changes in environmental pH, ultrasound, moisture, etc.
The gripping member 120 facilitates transmission of closing force (shown by arrows 128) generated by the contraction of the contracting elements 118 to the patient's skin. The transmitted force is illustrated as force vectors 130 in FIG. 2. The sealing drape 116 and gripping member 120 can work together to form a fluid seal over the patient's wound 102. “Fluid seal,” or “seal,” means a seal adequate to maintain reduced pressure at a desired site given the particular reduced-pressure source or subsystem involved.
The gripping member 120 may be any material suitable for transmitting the closing force from the contracting elements 118 to the patient's epidermis 104 (which may be deemed to include a gasket or other layer of material) or assist in forming a fluid seal over the wound 102. For example, the gripping member 120 may be a pressure-sensitive adhesive, heat-activated adhesive, sealing tape, double-sided sealing tape, paste, hydrocolloid, hydrogel, hooks, sutures, etc. In the illustrative embodiment, the gripping member 120 is an adhesive layer and spans the width of the second, tissue-facing surface 124 of the sealing drape 116 and overlays the contracting elements 118. It will be appreciated, however, that the gripping member 120 may merely be coupled to tissue-facing surfaces of the drape extensions 126. The gripping member 120 may be formed as a laminar layer or a pattern distributed on the sealing drape 116. Alternatively, in the case of sealing tape, the gripping member 120 may be applied over the entire first surface 122 of the sealing drape 116, or over the first surfaces of the drape extensions 126.
A manifold member 112, or manifold, is positionable between the second, tissue-facing surface 124 of the sealing drape 116 and at least a portion of the wound 102. The manifold member 112 may be sized to substantially cover the estimated area of the wound 102, although a larger or smaller size may be used in different applications. The manifold member 112 is made from a manifold material.
The term “manifold” as used herein generally refers to a substance or structure that is provided to assist in applying reduced pressure to, delivering fluids to, or removing fluids from the wound 102. The manifold member 112 typically includes a plurality of flow channels or pathways that distribute fluids provided to and removed from the wound 102 around the manifold member 112. In one illustrative embodiment, the flow channels or pathways are interconnected to improve distribution of fluids provided or removed from the wound 102. The manifold member 112 may be a biocompatible material that is capable of being placed in contact with wound 102 and distributing reduced pressure to the wound 102. Examples of manifold members 112 may include, for example, without limitation, devices that have structural elements arranged to form flow channels, such as, for example, cellular foam, open-cell foam, porous tissue collections, liquids, gels, and foams that include, or cure to include, flow channels. The manifold member 112 may be porous and may be made from foam, gauze, felted mat, or any other material suited to a particular biological application.
In one embodiment, the manifold member 112 is a porous foam and includes a plurality of interconnected cells or pores that act as flow channels. The porous foam may be a polyurethane, open-cell, reticulated foam, such as GranuFoam® material manufactured by Kinetic Concepts, Incorporated of San Antonio, Tex. Other embodiments may include “closed cells.” In some situations, the manifold member 112 may also be used to distribute fluids, such as medications, antibacterials, growth factors, and various solutions to the wound 102. Other layers may be included in or on the manifold member 112, such as absorptive materials, wicking materials, hydrophobic materials, and hydrophilic materials. In some instances it may be desirable to add ionic silver to the foam in a microbonding process or to add other substances to the manifold member 112, such as antimicrobial agents. The manifold member 112 may be isotropic or anisotropic depending on the exact orientation of the compressive forces that are desired during reduced pressure. In addition, the manifold material may be a bio-absorbable material.
The manifold member 112 may be coupled to the sealing drape 116. The coupling may occur in many ways. The sealing drape 116 and manifold member 112 may be coupled using adhesives such as an acrylic adhesive, silicone adhesive, hydrogel, hydrocolloid, etc. Alternatively, the sealing drape 116 and manifold member 112 may be bonded by heat bonding, ultrasonic bonding, and radio frequency bonding, etc. The coupling may occur in patterns or more completely. Structure might be added to the bond to make the sealing drape 116 behave anisotropically in a desired direction, i.e., to make an anisotropic drape material. An anisotropic drape material may work in conjunction with the contracting elements 118 to primarily move in a given direction, i.e., only about a certain axis or axes. For example, an anisotropic sealing drape may work in conjunction with the contracting elements to generate a closing force to assist in closing a wound.
The reduced-pressure subsystem 114 includes a reduced-pressure source 132, which can take many different forms. The reduced-pressure source 132 provides a reduced pressure as a part of the reduced-pressure, wound-treatment system 100. The reduced-pressure source 132 provides reduced pressure. The reduced-pressure source 132 may be any device for supplying a reduced pressure, such as a vacuum pump, wall suction, or other source. While the amount and nature of reduced pressure applied to a tissue site or wound will typically vary according to the application, the reduced pressure will typically be between −5 mm Hg and −500 mm Hg and more typically between −100 mm Hg and −300 mm Hg, and still more typically in the range −100 mm Hg and −200 mm Hg.
As used herein, “reduced pressure” generally refers to a pressure less than the ambient pressure at a tissue site or wound that is being subjected to treatment. In most cases, this reduced pressure will be less than the atmospheric pressure at which the patient is located. Alternatively, the reduced pressure may be less than a hydrostatic pressure at the tissue site. Unless otherwise indicated, values of pressure stated herein are gauge pressures. The reduced pressure delivered may be constant or varied (patterned or random) and may be delivered continuously or intermittently. Although the terms “vacuum” and “negative pressure” may be used to describe the pressure applied to the tissue site, the actual pressure applied to the tissue site may be more than the pressure normally associated with a complete vacuum. Consistent with the use herein, an increase in reduced pressure or vacuum pressure typically refers to a relative reduction in absolute pressure.
In the illustrative embodiment, the reduced-pressure source 132 is shown having a battery compartment 134 and a canister region 136 with windows 138 providing a visual indication of the level of fluid within the canister 136. An interposed membrane filter, such as hydrophobic or oleophobic filter, may be interspersed between a reduced-pressure delivery conduit, or tubing, 140 and the reduced-pressure source 132.
The reduced pressure developed by the reduced-pressure source 132 is delivered through the reduced-pressure delivery conduit 140 to a reduced-pressure interface 142, which may be an elbow port 144. In one illustrative embodiment, the elbow port 144 is a TRAC® technology port available from KCl of San Antonio, Tex. The reduced-pressure interface 142 allows the reduced pressure to be delivered to the wound-closing dressing 110 and realized within an interior portion of wound-closing dressing 110 as well as the manifold member 112. In this illustrative embodiment, the elbow port 144 extends through the sealing drape 116 to the manifold member 112.
One or more devices 141 may be added to the reduced-pressure delivery conduit 140. For example, the device 141 may be a fluid reservoir, or collection member, to hold exudates and other fluids removed. Other examples of devices 141 that may be included on the reduced-pressure delivery conduit 140 or otherwise fluidly coupled to the reduced-pressure delivery conduit 140 include the following non-limiting examples: a pressure-feedback device, a volume detection system, a blood detection system, an infection detection system, a flow monitoring system, a temperature monitoring system, etc. Some of these devices may be formed integral to the reduced-pressure source 132.
In operation, the reduced-pressure, wound-treatment system 100 may be applied to the wound 102 of the patient. The manifold member 112 is first placed over the wound 102. The manifold member 112 may be placed within the wound 102 or may overlay a portion of the wound 102. If the wound-closing dressing 110 has not been coupled to the manifold member 112, the wound-closing dressing 110 may then be placed over the top of the manifold member 112 such that drape extensions 126 of the sealing drape 116 extend beyond the periphery of the wound 102. The drape extensions 126 are secured to the patient's epidermis 104 by the gripping member 120 in order to form a fluid seal over the wound 102. The one or more contracting elements 118 may then be activated such that the contracting elements 118 generate a contracting force (shown by arrows 128) that is transmitted to the patient's epidermis 104 via the gripping member 120 so that wound edges 101 are drawn closer together.
The reduced-pressure interface 142 is applied, if not already installed, and the reduced-pressure delivery conduit 140 fluidly coupled at one end. The other end of the reduced-pressure delivery conduit 140 is fluidly coupled to the reduced-pressure source 132. The reduced-pressure source 132 may then be activated such that reduced pressure is delivered to the wound-closing dressing 110. Advantageously, if the contracting elements 118 are activated by moisture from a fluid, as discussed previously, application of reduced pressure may, in part, serve to draw the extra fluid out from the interior of the wound-closing dressing 110 and onto the contracting elements 118.
As the pressure is reduced, the manifold member 112 compresses and contracts laterally to form a semi-rigid substrate. The reduced pressure is transmitted further still through the manifold member 112 so that the reduced pressure is experienced at the patient's epidermis 104 and at the wound 102. The reduced pressure delivered to the manifold member 112 may develop a compressive force 146 that may provide stability and therapy. The compressive force 146 may be more than just at the top of the epidermis 104; the compressive force 146 may extend down deeper and may be experienced at the level of subcutaneous tissue 108.
As the sealing drape 116 and manifold member 112 laterally contract under the influence of the reduced pressure, and as the downward force acts through the Poisson's ratio for the epidermis 104, an inward force 148 may develop that may help hold an additional closing force on the wound 102 and may generally provide additional stability to the wound 102. Thus, the inward force 148 from the reduced pressure and the force 130 from the contracting elements 118 may act together to assist in closing the wound 102. At the same time, the reduced pressure delivered to and through the manifold member 112 helps to remove any exudates and other fluids from the wound 102 and provides reduced pressure therapy to the wound 102. All of these actions may improve healing of the wound 102.
Referring to FIG. 3A, the wound-closing dressing 110 is shown deployed on a wound 102 before the activation of the contracting elements 118. FIG. 3B shows the wound-closing dressing 110 after at least the three most inboard contracting elements 118 have contracted at least in part to provide a closing force as suggested by arrows 128.
It may be desirable to apply the reduced-pressure, wound-treatment system 100 in the operating room and allow the reduced-pressure, wound-treatment system 100 to remain on the patient until adequate healing has taken place. In this regard, it may be desirable to form the sealing drape 116, manifold member 112, and any other layers from transparent materials to allow the healthcare provider to gain visual cues about the healing of the wound 102 without having to remove the wound-closing dressing 110. Moreover, it should be appreciated that the reduced-pressure, wound-treatment system 100 may be used as a primary wound-closing treatment or as an intermediate step of a wound-closing treatment. Furthermore, it will be appreciated that the wound-closing dressing 110 may be used without the manifold member 112 or reduced-pressure subsystem 114. The wound-closing dressing 110 may be beneficial as a stand-alone bandage that is capable of delivering a closing force to a wound 102 without requiring reduced pressure.
Referring now primarily to FIGS. 4A and 4B, an illustrative embodiment of a wound-closing dressing 210 is shown. The wound-closing dressing 210 is analogous in most respects to the wound-closing dressing 110 and related components of FIGS. 1-3B and a correlation of parts is generally indicated in this embodiment by indexing the numerals by 100. For example, sealing drape 216 is analogous to sealing drape 116. While presented as a separate wound-closing dressing, the wound-closing dressing 210 could be used as part of a reduced-pressure system, such as the reduced-pressure, wound-treatment system 100. The wound-closing dressing 210 may be shaped to approximate the shape of a wound 202 or extend beyond the wound 202. While the plan view of wound-closing dressing 210 is shown as substantially circular, it will be appreciated that the wound-closing dressing 210 may have any suitable plan view, including, but not limited to, square, rectangular, triangular, elliptical, hexagonal, octagonal, irregular, etc. The contracting elements 218 may be woven together in a “thatched” pattern such that, when activated, a substantially equal closing force (represented by arrows 228 in FIG. 4B) may be distributed about an entire periphery 203 of the wound 202. FIG. 4A shows the wound-closing dressing 210 and wound 202 prior to activation of the contracting elements 218, and FIG. 4B shows the wound-closing dressing 210 and wound 202 after the contracting elements 218 have been activated.
Referring now primarily to FIG. 5, another illustrative reduced-pressure, wound-closure system 300 for treating a wound 302 on a patient is shown. The system is generally analogous in most respects to that of the reduced-pressure, wound-treatment system 100 of FIGS. 1-3B. Analogous parts are indicated by indexing the reference numerals of FIGS. 1-3B by 200. In this illustrative embodiment, a plurality of contracting elements 318 and backing strips 350 may be utilized. Each contracting element 318 and corresponding backing strip 350 form a contracting strip 352. Hence a plurality of contracting strips 352 may be utilized. Each contracting element 318 is releasably coupled to the corresponding backing strip 350. As before, the contracting element 318 is configured to contract when activated in order to generate a closing force that may assist in closing the wound 302. The contracting elements 318 may be releasably coupled to the backing strip 350 in a stretched position or may be moved to a stretched position as the contracting strip 352 is applied to the patient. In either case, when the contracting element 318 is activated, the contracting element 318 seeks to return to a non-stretched position, or free position, and thereby contracts to generate a closing force.
While the illustrative embodiment shows each contracting strip 352 as having a single contracting element 318, it will be appreciated that any suitable number of contracting elements 318 may be employed. Furthermore, in the event that the contracting strip 352 includes a plurality of contracting elements 318, the plurality of contracting elements 318 may be arranged in any suitable pattern relative to one another, e.g., parallel, perpendicular, angled, etc. While a plurality of contracting elements 318, backing strips 350, and contracting strips 352 are mentioned, single members of each may be used as well. As with other embodiments, the contracting element 318 may be formed from any suitable material that contracts in response to being activated and may be activated in numerous ways.
The backing strips 350 may be formed from any suitable material including, but not limited to, gauze, an elastomer, an adhesive, etc. Any suitable number of contracting strips 352 may be placed over the wound 302 and a manifold member, e.g., the manifold member 112 in FIG. 2. Each contracting strip 352 may be secured to epidermis by corresponding gripping members in any suitable pattern to assist in closing the wound 302. A sealing drape 316 having a reduced-pressure interface 342 may be placed over the contracting strips 352 such that a reduced pressure may be delivered to the wound 302; alternatively or in addition, the contracting strips 352 may be placed atop the sealing drape 316. In an alternative embodiment, the backing strip 350 of each contracting strip 352 employed may be formed from a drape material whereby each backing strip 350 works together with one or more adjacent backing strips 350 so as to form an unified drape thereby eliminating the need for an additional sealing drape; in this embodiment, it may be desirable to use a gripping member (e.g., an adhesive) having a high Moisture Vapor Transfer Rate (MVTR). In yet another alternative embodiment, the contracting strips 352 may be used as stand-alone components (e.g., without the manifold and reduced pressure subsystem) to assist in closing a wound.
Referring now primarily to FIG. 6, another illustrative, non-limiting embodiment of a reduced-pressure, wound-closure system 400 for treating a wound 402 is presented. The reduced-pressure, wound-closure system 400 is generally analogous in most respects to that of the reduced-pressure, wound-treatment system 100 of FIGS. 1-3B and analogous parts are indicated by indexing the reference numerals of FIG. 1-3B by 300. Contracting elements 418 are arranged in a “star-shaped” pattern to deliver substantially equal closing forces to a periphery 401 of a wound 402. The contracting elements 418 include a central aperture 454 for receiving a reduced-pressure interface 442 therethrough. While the illustrative contracting elements 418 are shown as having eight “legs”, it will be appreciated that the contracting elements 418 may include any suitable number of legs and may be made as an integrated unit as shown or by a plurality of components.
Reference is now made primarily to FIG. 7A, which is a schematic bottom view of a portion of an illustrative embodiment of a system for treating a wound, and FIG. 7B. These figures include an alternative embodiment of a wound-closing dressing 500 for closing a wound. The wound-closing dressing 500 includes a sealing drape 502, a dissolvable body 504, an elastic member 506, and a gripping member 508. The wound-closing dressing 500 may be used as a stand-alone component to assist in wound closure or may be used as part of a reduced-pressure system to assist in wound closure and treatment. The sealing drape 502 includes a first surface 510 and a second, tissue-facing surface 512. The sealing drape 502 generally may be formed from the same or similar materials to that of the sealing drape 116 of FIGS. 1-3B and may operate in a like manner. Optionally, the sealing drape 502 may be fenestrated to permit moisture to pass from the first surface 510 to the dissolvable body 504.
The dissolvable body 504 is coupled to the second, tissue-facing surface 512 of the sealing drape 502. The dissolvable body 504 may be formed from any suitable dissolvable material, including, but not limited to, biodegradable or bioabsorbable materials, such as polylactide (PLA), poly(lactic-co-glycolic acid) (PLGA), polyglycolide (PGA), polycaprolactone (PCL), sodium chloride, or the like. Additionally, the dissolvable body 504 may include oxygenated particles or anti-microbial particles for reducing infection. The dissolvable body 504, which holds the elastic member 506 in a stretched position, may dissolve under the influence of any suitable factor, including, but not limited to, moisture, heat, ultrasound, etc. When the dissolvable body 504 dissolves, the elastic member 506 is, at least partially, released thereby generating a closing force as the elastic member 506 seeks to return to an unstretched position. While the illustrative embodiment shows a single dissolvable body 504, it will be appreciated that any suitable number of dissolvable bodies may be employed (see e.g., FIGS. 8-9B).
The elastic member 506 is coupled to the dissolvable body 504 in a stretched position such that when the dissolvable body 504, or a portion thereof, dissolves, the elastic member 506 contracts to generate a closing force. The elastic member 506 may be coupled to the dissolvable body 504 by any suitable device or technique, including, but not limited to adhesive, mechanical fasteners, bonding, sonic welding, etc. Alternatively or in addition, the elastic member 506 may be coupled by embedding the elastic member 506 in the dissolvable body 504. The elastic member 506 may be any suitable material that is capable of being coupled to the dissolvable body 504 in a stretched position and capable of contracting when at least a portion of the dissolvable body 504 dissolves. For example and without limitation, the elastic member 506 may be formed from an elastomer. As used herein, the term “coupled” includes coupling via a separate object and includes direct coupling. The term “coupled” also encompasses two or more components that are continuous with one another by virtue of each of the components being formed from the same piece of material. Also, the term “coupled” may include chemical, such as via a chemical bond, mechanical, thermal, or electrical coupling. Coupling may further include embedding one member in another.
As clearly shown in FIG. 7B, the elastic member 506 in this illustrative embodiment has a substantially circular cross-section. It will be appreciated, however, that the elastic member 506 may have any suitable cross-section. Moreover, it will be appreciated that the elastic member 506 may have any suitable configuration. For example, the elastic member 506 may be arranged in a “thatched” pattern, a cross pattern, parallel pattern, etc. Also, while the illustrative embodiment shows a single elastic member 506, it will be appreciated that any suitable number of elastic members 506 may be coupled to the dissolvable body 504 or bodies 504. Also, the ends of the elastic member 506 may be coupled to the sealing drape 502 such that the contracting force generated by the elastic member 506 may be directly transferred to the gripping member 508 (as discussed further below).
The gripping member 508 is the same or similar to that of the gripping member 120 in the reduced-pressure, wound-treatment system 100 of FIGS. 1-3B. The gripping member 508 may be coupled to at least one of the sealing drape 502, dissolvable body 504, or elastic member 506. The gripping member 508 is configured to transfer the force generated by the contracting of the elastic member 506 to the patient's epidermis to assist in closing a wound. Optionally, as best shown in FIG. 7B, the wound-closing dressing 500 may also include a fenestrated sheet 514 that is disposed between the dissolvable body 504 and the wound in order to regulate the amount of moisture from the patient's exudate that is permitted to pass to the dissolvable body 504. This may be useful to control the amount or rate that the dissolvable body 504 dissolves in instances where the dissolvable body 504 dissolves when moisture is introduced thereto.
Referring now primarily to FIGS. 8-9B, another wound-closing dressing 610 for treating a wound 602 is shown. The wound-closing dressing 610 is generally analogous in most respects to that of the wound-closing dressing 500 of FIGS. 7A and 7B. Analogous parts are indicated by indexing the reference numerals of FIGS. 7A and 7B by 100. In this embodiment, a dissolvable body 604 includes a plurality of dissolvable beads 618 or other dissolvable members. The plurality of dissolvable beads 618 hold the force generated by a stretched elastic member 606, and so as the plurality of dissolvable beads 618 are dissolved, an increasing force is experienced by a gripping member (not shown) that is attached to the elastic member 606. The beads 618 are typically dissolved by exudate from the wound 602. When a bead 618 dissolves, the contracting force generated by the corresponding elastic member 606 increases. The generated closing force may have a direct relationship to the number of beads 618 that are dissolved. For example, as the number of beads 618 dissolved increases, the generated closing force may increase with a defined relationship, e.g., linearly, exponentially, etc.
Thus, as clearly shown in FIGS. 9A and 9B, the wound-closing dressing 610 may be “tuned” to generate a greater closing force at the wider portions of the wound 602. Moreover, this may occur in a self-regulating way. In other words, areas of the wound 602 that have increased levels of exudate, typically the wider portions of the wound 602, experience a greater closing force because the increased levels of exudate cause more beads 618 to dissolve which increases the closing force generated by the elastic member 606. The wound-closing dressing 610 may be used in conjunction with a sealing drape and gripping member similar to those of the wound-closing dressing 510 of FIGS. 7A and 7B and as part of a reduced-pressure treatment system. Alternatively, each end of each elastic member 606 may be secured to the patient's epidermis and the wound-closing dressing 610 used as a stand-alone dressing for assisting in wound closure.
Although the present invention and its advantages have been disclosed in the context of certain illustrative, non-limiting embodiments, it should be understood that various changes, substitutions, permutations, and alterations can be made without departing from the scope of the invention as defined by the appended claims. It will be appreciated that any feature that is described in a connection to any one embodiment may also be applicable to any other embodiment.

Claims (16)

What is claimed:
1. A reduced-pressure, wound-treatment system for treating a wound on a patient, the system comprising:
a wound-closing dressing comprising:
a sealing drape having a first surface and a tissue-facing surface, a contracting element coupled to the tissue-facing surface of the sealing drape,
a dissolvable body coupled to the contracting element wherein the contracting element is adapted to be activated when at least a portion of the dissolvable body dissolves, and
a gripping member coupled to the tissue-facing surface of the sealing drape over the contracting element;
a manifold member for disposing between the fenestrated gripping member and the wound; and
a reduced-pressure subsystem in fluid communication with the manifold member and adapted to deliver a reduced pressure to the wound.
2. The system of claim 1 wherein said contracting element is configured to move from an extended position to a contracted position, and wherein the contracting element is initially in the extended position.
3. The system of claim 1 wherein said contracting element comprises a weave of contracting strips.
4. The system of claim 1 wherein said contracting element is releasably coupled to a backing strip.
5. The system of claim 1 wherein said contracting element comprises a plurality of contracting strips.
6. The system of claim 1 wherein said gripping member comprises an adhesive.
7. The system of claim 1 wherein the dissolvable body comprises a plurality of dissolvable beads.
8. The system of claim 1 wherein said contracting element comprises a plurality of legs positioned in star-shaped pattern about a central aperture.
9. A wound-closing dressing comprising:
a sealing drape having a first surface and a tissue-facing surface,
a contracting element coupled to the tissue-facing surface of the sealing drape;
a dissolvable body coupled to the contracting element wherein the contracting element is adapted to be activated when at least a portion of the dissolvable body dissolves; and
a gripping member coupled to the tissue-facing surface of the sealing drape over the contracting element.
10. The wound-closing dressing of claim 9 wherein said contracting element is in an extended position prior to activation.
11. The wound-closing dressing of claim 9 wherein said contracting element comprises a weave of contracting strips.
12. The wound-closing dressing of claim 9 wherein said contracting element is releasably coupled to a backing strip.
13. The wound-closing dressing of claim 9 wherein said contracting element comprises a plurality of contracting strips.
14. The wound-closing dressing of claim 9 wherein said gripping member comprises an adhesive.
15. The wound-closing dressing of claim 9 wherein said gripping member comprises an adhesive and wherein said adhesive is a pressure-sensitive adhesive.
16. The wound-closing dressing of claim 9 wherein the dissolvable body comprises a plurality of dissolvable beads.
US12/610,910 2008-11-07 2009-11-02 Reduced-pressure, wound-treatment dressings and systems Active 2031-02-26 US8460257B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US12/610,910 US8460257B2 (en) 2008-11-07 2009-11-02 Reduced-pressure, wound-treatment dressings and systems
US13/894,217 US10398603B2 (en) 2008-11-07 2013-05-14 Reduced-pressure, wound-treatment dressings and systems
US16/445,921 US20190298577A1 (en) 2008-11-07 2019-06-19 Reduced-pressure, wound-treatment dressings and systems

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11237108P 2008-11-07 2008-11-07
US12/610,910 US8460257B2 (en) 2008-11-07 2009-11-02 Reduced-pressure, wound-treatment dressings and systems

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/894,217 Division US10398603B2 (en) 2008-11-07 2013-05-14 Reduced-pressure, wound-treatment dressings and systems

Publications (2)

Publication Number Publication Date
US20100121286A1 US20100121286A1 (en) 2010-05-13
US8460257B2 true US8460257B2 (en) 2013-06-11

Family

ID=42153198

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/610,910 Active 2031-02-26 US8460257B2 (en) 2008-11-07 2009-11-02 Reduced-pressure, wound-treatment dressings and systems
US13/894,217 Active 2033-01-31 US10398603B2 (en) 2008-11-07 2013-05-14 Reduced-pressure, wound-treatment dressings and systems
US16/445,921 Abandoned US20190298577A1 (en) 2008-11-07 2019-06-19 Reduced-pressure, wound-treatment dressings and systems

Family Applications After (2)

Application Number Title Priority Date Filing Date
US13/894,217 Active 2033-01-31 US10398603B2 (en) 2008-11-07 2013-05-14 Reduced-pressure, wound-treatment dressings and systems
US16/445,921 Abandoned US20190298577A1 (en) 2008-11-07 2019-06-19 Reduced-pressure, wound-treatment dressings and systems

Country Status (12)

Country Link
US (3) US8460257B2 (en)
EP (2) EP3421020B1 (en)
JP (2) JP2012508037A (en)
KR (1) KR101644206B1 (en)
CN (1) CN102202619B (en)
AU (1) AU2009311352B2 (en)
BR (1) BRPI0916062A2 (en)
CA (1) CA2742962C (en)
MX (1) MX2011004820A (en)
RU (1) RU2011114000A (en)
TW (1) TW201021862A (en)
WO (1) WO2010053870A1 (en)

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD733896S1 (en) 2012-05-04 2015-07-07 Genadyne Biotechnologies, Inc. Abdominal dressing
US9226737B2 (en) 2011-02-04 2016-01-05 University Of Massachusetts Negative pressure wound closure device
US9370450B2 (en) 2009-02-13 2016-06-21 Smith & Nephew Plc Wound packing
WO2016108585A1 (en) * 2015-01-02 2016-07-07 가톨릭관동대학교산학협력단 Medical magnet band
KR20160083780A (en) * 2015-01-02 2016-07-12 가톨릭관동대학교산학협력단 Medical magnet bandage
US9421132B2 (en) 2011-02-04 2016-08-23 University Of Massachusetts Negative pressure wound closure device
US9770369B2 (en) 2014-08-08 2017-09-26 Neogenix, Llc Wound care devices, apparatus, and treatment methods
US9820888B2 (en) 2006-09-26 2017-11-21 Smith & Nephew, Inc. Wound dressing
US9844472B2 (en) 2012-05-22 2017-12-19 Smith & Nephew Plc Wound closure device
US9962295B2 (en) 2012-07-16 2018-05-08 Smith & Nephew, Inc. Negative pressure wound closure device
US10070994B2 (en) 2012-05-22 2018-09-11 Smith & Nephew Plc Apparatuses and methods for wound therapy
US10117782B2 (en) 2012-05-24 2018-11-06 Smith & Nephew, Inc. Devices and methods for treating and closing wounds with negative pressure
US10124098B2 (en) 2013-03-13 2018-11-13 Smith & Nephew, Inc. Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure
US10159771B2 (en) 2013-03-14 2018-12-25 Smith & Nephew Plc Compressible wound fillers and systems and methods of use in treating wounds with negative pressure
US10179073B2 (en) 2014-01-21 2019-01-15 Smith & Nephew Plc Wound treatment apparatuses
US10201642B2 (en) 2014-01-21 2019-02-12 Smith & Nephew Plc Collapsible dressing for negative pressure wound treatment
US10220125B2 (en) 2012-02-03 2019-03-05 Smith & Nephew Plc Apparatuses and methods for wound therapy
US10226566B2 (en) 2014-04-23 2019-03-12 Genadyne Biotechnologies, Inc. System and process for removing bodily fluids from a body opening
US10441474B1 (en) 2014-05-27 2019-10-15 Barakat Alhammadin Bandage for applying arterial pressure
US10575991B2 (en) 2015-12-15 2020-03-03 University Of Massachusetts Negative pressure wound closure devices and methods
US10660992B2 (en) 2013-10-21 2020-05-26 Smith & Nephew, Inc. Negative pressure wound closure device
US10695472B2 (en) 2008-03-13 2020-06-30 Smith & Nephew Plc Vacuum closure device
US10814049B2 (en) 2015-12-15 2020-10-27 University Of Massachusetts Negative pressure wound closure devices and methods
US11096832B2 (en) 2016-09-27 2021-08-24 Smith & Nephew Plc Wound closure devices with dissolvable portions
US11123476B2 (en) 2017-06-14 2021-09-21 Smith & Nephew, Inc. Fluid removal management and control of wound closure in wound therapy
US11135351B2 (en) 2016-08-30 2021-10-05 Smith & Nephew Plc Systems and methods for applying reduced pressure therapy
US11324876B2 (en) 2017-06-13 2022-05-10 Smith & Nephew Plc Collapsible structure and method of use
US11375923B2 (en) 2017-08-29 2022-07-05 Smith & Nephew Plc Systems and methods for monitoring wound closure
US11395873B2 (en) 2017-06-14 2022-07-26 Smith & Nephew, Inc. Control of wound closure and fluid removal management in wound therapy
US11439539B2 (en) * 2015-04-29 2022-09-13 University Of Massachusetts Negative pressure wound closure device
US11471586B2 (en) 2015-12-15 2022-10-18 University Of Massachusetts Negative pressure wound closure devices and methods
US11491265B2 (en) 2017-02-22 2022-11-08 Cornell University Mechanical vacuum dressing for mechanically managing, protecting and suctioning small incisional wounds
US11583623B2 (en) 2017-06-14 2023-02-21 Smith & Nephew Plc Collapsible structure for wound closure and method of use
US11590030B2 (en) 2017-08-07 2023-02-28 Smith & Nephew Plc Wound closure device with protective layer and method of use
US11607344B2 (en) 2017-07-27 2023-03-21 Smith & Nephew Plc Customizable wound closure device and method of use
US11617684B2 (en) 2016-11-02 2023-04-04 Smith & Nephew, Inc. Wound closure devices
US11724020B2 (en) 2017-06-14 2023-08-15 Smith & Nephew Plc Collapsible sheet for wound closure and method of use
US11839527B2 (en) 2017-12-06 2023-12-12 Cornell University Manually-operated negative pressure wound therapy (NPWT) bandage with improved pump efficiency, automatic pressure indicator and automatic pressure limiter
US11872110B2 (en) 2017-06-13 2024-01-16 Smith & Nephew Plc Wound closure device and method of use

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
GB0325129D0 (en) 2003-10-28 2003-12-03 Smith & Nephew Apparatus in situ
US7708724B2 (en) * 2004-04-05 2010-05-04 Blue Sky Medical Group Incorporated Reduced pressure wound cupping treatment system
US7776028B2 (en) 2004-04-05 2010-08-17 Bluesky Medical Group Incorporated Adjustable overlay reduced pressure wound treatment system
US7909805B2 (en) 2004-04-05 2011-03-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US8062272B2 (en) 2004-05-21 2011-11-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US10058642B2 (en) 2004-04-05 2018-08-28 Bluesky Medical Group Incorporated Reduced pressure treatment system
WO2007030601A2 (en) 2005-09-06 2007-03-15 Tyco Healthcare Group Lp Self contained wound dressing with micropump
US7779625B2 (en) 2006-05-11 2010-08-24 Kalypto Medical, Inc. Device and method for wound therapy
JP5613566B2 (en) 2007-11-21 2014-10-22 スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company Wound dressing
CA2705898C (en) 2007-11-21 2020-08-25 Smith & Nephew Plc Wound dressing
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
CA2757841C (en) 2009-04-10 2018-06-12 Spiracur, Inc. Methods and devices for applying closed incision negative pressure wound therapy
US8444614B2 (en) * 2009-04-10 2013-05-21 Spiracur, Inc. Methods and devices for applying closed incision negative pressure wound therapy
EP2419157A4 (en) 2009-04-17 2018-01-03 Kalypto Medical, Inc. Negative pressure wound therapy device
CA2773915A1 (en) 2009-09-17 2011-04-14 Zipline Medical, Inc. Rapid closing surgical closure device
US10159825B2 (en) 2009-09-17 2018-12-25 Zipline Medical, Inc. Rapid closing surgical closure device
US8721606B2 (en) 2010-03-11 2014-05-13 Kci Licensing, Inc. Dressings, systems, and methods for treating a tissue site
US20190381222A9 (en) * 2010-04-16 2019-12-19 Kci Licensing, Inc. Reduced-Pressure Sources, Systems, And Methods Employing A Polymeric, Porous, Hydrophobic Material
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
US8439945B2 (en) 2010-05-03 2013-05-14 Zipline Medical, Inc. Methods for biopsying tissue
EP2579828B1 (en) 2010-06-14 2018-06-13 Zipline Medical Inc. Apparatus for inhibiting scar formation
US9265665B2 (en) * 2010-07-19 2016-02-23 Kci Licensing, Inc. Inflatable off-loading wound dressing assemblies, systems, and methods
CA140188S (en) 2010-10-15 2011-11-07 Smith & Nephew Medical dressing
CA140189S (en) 2010-10-15 2011-11-07 Smith & Nephew Medical dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
EP2648793B1 (en) 2010-12-08 2020-03-11 ConvaTec Technologies Inc. Integrated system for assessing wound exudates
US9526816B2 (en) 2010-12-08 2016-12-27 Convatec Technologies Inc. Wound exudate monitor accessory
US9058634B2 (en) 2011-05-24 2015-06-16 Kalypto Medical, Inc. Method for providing a negative pressure wound therapy pump device
AU2011368701A1 (en) 2011-05-24 2013-12-12 Smith & Nephew, Inc. Device with controller and pump modules for providing negative pressure for wound therapy
US9067003B2 (en) 2011-05-26 2015-06-30 Kalypto Medical, Inc. Method for providing negative pressure to a negative pressure wound therapy bandage
EP2723286B2 (en) * 2011-06-24 2021-10-13 KCI Licensing, Inc. Reduced-pressure dressings employing tissue-fixation elements
MX2014000526A (en) 2011-07-14 2014-10-01 Smith & Nephew Wound dressing and method of treatment.
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
EP2758086B1 (en) * 2011-09-20 2018-05-23 KCI Licensing, Inc. Tissue treatment systems and methods having a non-tactile-stimulus-activated, macroscopically-deforming material
US9198803B1 (en) 2011-09-26 2015-12-01 David S. London Dressing device for offloading and treating an ulcer
CA2850639A1 (en) * 2011-10-17 2013-04-25 Kci Licensing, Inc. System and apparatus for treating a tissue site having an in-line canister
US8323313B1 (en) 2011-11-01 2012-12-04 Zipline Medical, Inc. Surgical incision and closure apparatus with integrated force distribution
US9561034B2 (en) 2011-11-01 2017-02-07 Zipline Medical, Inc. Surgical incision and closure apparatus
US10123801B2 (en) 2011-11-01 2018-11-13 Zipline Medical, Inc. Means to prevent wound dressings from adhering to closure device
US9050086B2 (en) 2011-11-01 2015-06-09 Zipline Medical, Inc. Surgical incision and closure apparatus
US10123800B2 (en) 2011-11-01 2018-11-13 Zipline Medical, Inc. Surgical incision and closure apparatus with integrated force distribution
ES2672230T3 (en) * 2011-11-02 2018-06-13 Smith & Nephew Plc Reduced pressure therapy devices
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
GB201120693D0 (en) 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
AU346291S (en) 2012-05-15 2013-01-09 Smith & Nephew Medical dressing
CA2874509C (en) 2012-05-23 2021-01-26 Smith & Nephew Plc Apparatuses and methods for negative pressure wound therapy
US20150354096A1 (en) 2012-12-20 2015-12-10 Convatec Technologies Inc. Processing of chemically modified cellulosic fibres
US9737649B2 (en) 2013-03-14 2017-08-22 Smith & Nephew, Inc. Systems and methods for applying reduced pressure therapy
MX2015011812A (en) * 2013-03-14 2016-07-05 Smith & Nephew Inc Systems and methods for applying reduced pressure therapy.
EP2981218A1 (en) * 2013-03-29 2016-02-10 Koninklijke Philips N.V. Force feedback gripping device with a magnetorheological based actuator
US9675504B2 (en) * 2013-08-28 2017-06-13 Lisa Ann Myers Disposable water resistant protective cover cast and wound sites
JP2017502762A (en) 2014-01-05 2017-01-26 ジップライン メディカル, インコーポレイテッドZipline Medical, Inc. Wound closure device with equipment
CN104188705B (en) * 2014-09-11 2016-10-05 黄成� Moulding of a kind of hemostasis
US20190175415A1 (en) * 2015-07-24 2019-06-13 Nichiban Co., Ltd. Skin closure tape or reinforcing tape used after skin suture
AU2017239643B2 (en) 2016-03-30 2021-08-12 Convatec Technologies Inc. Detecting microbial infections in wounds
US20230213525A1 (en) 2016-03-30 2023-07-06 Qualizyme Diagnostics Gmbh & Co Kg Detecting microbial infection in wounds
US11596554B2 (en) 2016-07-08 2023-03-07 Convatec Technologies Inc. Flexible negative pressure system
BR112019000316A2 (en) 2016-07-08 2019-04-16 Convatec Technologies Inc. fluid flow detection
CN109640904A (en) 2016-07-08 2019-04-16 康沃特克科技公司 Fluid collection device
JP6361844B1 (en) * 2016-09-23 2018-07-25 株式会社村田製作所 Negative pressure closure therapy device
US11096817B2 (en) * 2016-10-19 2021-08-24 6D Tape Inc Therapy tape to aid patient recovery
GB2555584B (en) 2016-10-28 2020-05-27 Smith & Nephew Multi-layered wound dressing and method of manufacture
WO2018081795A1 (en) 2016-10-31 2018-05-03 Zipline Medical, Inc. Systems and methods for monitoring physical therapy of the knee and other joints
CN106726146A (en) * 2017-01-18 2017-05-31 柴家科 For the negative pressure wound surface therapeutic system of Wound treating
US11896464B2 (en) 2018-04-13 2024-02-13 Kci Licensing, Inc. Method to dynamically measure apposition and patient limb movement in a negative pressure closed incision dressing
US11406750B2 (en) 2018-04-13 2022-08-09 Kci Licensing, Inc. Compression strain and negative pressure delivery indicator for a wound dressing
GB2574074B (en) 2018-07-27 2020-05-20 Mclaren Applied Tech Ltd Time synchronisation
CN109124712B (en) * 2018-09-20 2021-05-07 上海锦辰医药科技有限公司 Wound closure device
WO2020166744A1 (en) * 2019-02-15 2020-08-20 주식회사 하이로닉 Skin lifting method using microneedle having deformed structure and skin dressing pad
CN109938920B (en) * 2019-04-29 2024-02-20 振德医疗用品股份有限公司 Micro negative pressure foam dressing and manufacturing method thereof
EP3983028A1 (en) * 2019-06-17 2022-04-20 KCI Licensing, Inc. Abdominal negative-pressure therapy dressing with closed-loop force management control
GB2588236A (en) 2019-10-18 2021-04-21 Mclaren Applied Tech Ltd Gyroscope bias estimation
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
CN113786282A (en) * 2021-09-15 2021-12-14 电子科技大学 Heat-activation-electricity cooperative dressing for accelerating wound healing and preparation method thereof
CN114432044B (en) * 2022-01-22 2023-06-09 佛山市耐思得卫生用品有限公司 Sanitary towel

Citations (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1355846A (en) 1920-02-06 1920-10-19 David A Rannells Medical appliance
US2012755A (en) * 1934-07-12 1935-08-27 Muth Otto De Surgical dressing
US2547758A (en) 1949-01-05 1951-04-03 Wilmer B Keeling Instrument for treating the male urethra
US2632443A (en) 1949-04-18 1953-03-24 Eleanor P Lesher Surgical dressing
GB692578A (en) 1949-09-13 1953-06-10 Minnesota Mining & Mfg Improvements in or relating to drape sheets for surgical use
US2682873A (en) 1952-07-30 1954-07-06 Johnson & Johnson General purpose protective dressing
US2910763A (en) 1955-08-17 1959-11-03 Du Pont Felt-like products
US2969057A (en) 1957-11-04 1961-01-24 Brady Co W H Nematodic swab
US3066672A (en) 1960-09-27 1962-12-04 Jr William H Crosby Method and apparatus for serial sampling of intestinal juice
US3367332A (en) 1965-08-27 1968-02-06 Gen Electric Product and process for establishing a sterile area of skin
US3520300A (en) 1967-03-15 1970-07-14 Amp Inc Surgical sponge and suction device
US3568675A (en) 1968-08-30 1971-03-09 Clyde B Harvey Fistula and penetrating wound dressing
US3648692A (en) 1970-12-07 1972-03-14 Parke Davis & Co Medical-surgical dressing for burns and the like
US3682180A (en) 1970-06-08 1972-08-08 Coilform Co Inc Drain clip for surgical drain
US3826254A (en) 1973-02-26 1974-07-30 Verco Ind Needle or catheter retaining appliance
DE2640413A1 (en) 1976-09-08 1978-03-09 Wolf Gmbh Richard CATHETER MONITORING DEVICE
US4080970A (en) 1976-11-17 1978-03-28 Miller Thomas J Post-operative combination dressing and internal drain tube with external shield and tube connector
US4096853A (en) 1975-06-21 1978-06-27 Hoechst Aktiengesellschaft Device for the introduction of contrast medium into an anus praeter
US4139004A (en) 1977-02-17 1979-02-13 Gonzalez Jr Harry Bandage apparatus for treating burns
US4165748A (en) 1977-11-07 1979-08-28 Johnson Melissa C Catheter tube holder
US4184510A (en) 1977-03-15 1980-01-22 Fibra-Sonics, Inc. Valued device for controlling vacuum in surgery
US4233969A (en) 1976-11-11 1980-11-18 Lock Peter M Wound dressing materials
US4245630A (en) 1976-10-08 1981-01-20 T. J. Smith & Nephew, Ltd. Tearable composite strip of materials
US4256109A (en) 1978-07-10 1981-03-17 Nichols Robert L Shut off valve for medical suction apparatus
US4261363A (en) 1979-11-09 1981-04-14 C. R. Bard, Inc. Retention clips for body fluid drains
US4275721A (en) 1978-11-28 1981-06-30 Landstingens Inkopscentral Lic, Ekonomisk Forening Vein catheter bandage
US4284079A (en) 1979-06-28 1981-08-18 Adair Edwin Lloyd Method for applying a male incontinence device
US4297995A (en) 1980-06-03 1981-11-03 Key Pharmaceuticals, Inc. Bandage containing attachment post
US4333468A (en) 1980-08-18 1982-06-08 Geist Robert W Mesentery tube holder apparatus
US4373519A (en) 1981-06-26 1983-02-15 Minnesota Mining And Manufacturing Company Composite wound dressing
US4382441A (en) 1978-12-06 1983-05-10 Svedman Paul Device for treating tissues, for example skin
US4392853A (en) 1981-03-16 1983-07-12 Rudolph Muto Sterile assembly for protecting and fastening an indwelling device
US4392858A (en) 1981-07-16 1983-07-12 Sherwood Medical Company Wound drainage device
US4419097A (en) 1981-07-31 1983-12-06 Rexar Industries, Inc. Attachment for catheter tube
EP0100148A1 (en) 1982-07-06 1984-02-08 Dow Corning Limited Medical-surgical dressing and a process for the production thereof
US4465485A (en) 1981-03-06 1984-08-14 Becton, Dickinson And Company Suction canister with unitary shut-off valve and filter features
EP0117632A2 (en) 1983-01-27 1984-09-05 Johnson & Johnson Products Inc. Adhesive film dressing
US4475909A (en) 1982-05-06 1984-10-09 Eisenberg Melvin I Male urinary device and method for applying the device
US4480638A (en) 1980-03-11 1984-11-06 Eduard Schmid Cushion for holding an element of grafted skin
US4525166A (en) 1981-11-21 1985-06-25 Intermedicat Gmbh Rolled flexible medical suction drainage device
US4525374A (en) 1984-02-27 1985-06-25 Manresa, Inc. Treating hydrophobic filters to render them hydrophilic
US4540412A (en) 1983-07-14 1985-09-10 The Kendall Company Device for moist heat therapy
US4543100A (en) 1983-11-01 1985-09-24 Brodsky Stuart A Catheter and drain tube retainer
US4548202A (en) 1983-06-20 1985-10-22 Ethicon, Inc. Mesh tissue fasteners
US4551139A (en) 1982-02-08 1985-11-05 Marion Laboratories, Inc. Method and apparatus for burn wound treatment
EP0161865A2 (en) 1984-05-03 1985-11-21 Smith and Nephew Associated Companies p.l.c. Adhesive wound dressing
US4569348A (en) 1980-02-22 1986-02-11 Velcro Usa Inc. Catheter tube holder strap
AU550575B2 (en) 1981-08-07 1986-03-27 Richard Christian Wright Wound drainage device
US4605399A (en) 1984-12-04 1986-08-12 Complex, Inc. Transdermal infusion device
US4608041A (en) 1981-10-14 1986-08-26 Frese Nielsen Device for treatment of wounds in body tissue of patients by exposure to jets of gas
US4640688A (en) 1985-08-23 1987-02-03 Mentor Corporation Urine collection catheter
US4655754A (en) 1984-11-09 1987-04-07 Stryker Corporation Vacuum wound drainage system and lipids baffle therefor
US4664662A (en) 1984-08-02 1987-05-12 Smith And Nephew Associated Companies Plc Wound dressing
US4710165A (en) 1985-09-16 1987-12-01 Mcneil Charles B Wearable, variable rate suction/collection device
US4733659A (en) 1986-01-17 1988-03-29 Seton Company Foam bandage
GB2195255A (en) 1986-09-30 1988-04-07 Vacutec Uk Limited Method and apparatus for vacuum treatment of an epidermal surface
US4743232A (en) 1986-10-06 1988-05-10 The Clinipad Corporation Package assembly for plastic film bandage
GB2197789A (en) 1986-11-28 1988-06-02 Smiths Industries Plc Anti-foaming disinfectants used in surgical suction apparatus
US4758220A (en) 1985-09-26 1988-07-19 Alcon Laboratories, Inc. Surgical cassette proximity sensing and latching apparatus
US4787888A (en) 1987-06-01 1988-11-29 University Of Connecticut Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a)
US4826494A (en) 1984-11-09 1989-05-02 Stryker Corporation Vacuum wound drainage system
US4838883A (en) 1986-03-07 1989-06-13 Nissho Corporation Urine-collecting device
US4840187A (en) 1986-09-11 1989-06-20 Bard Limited Sheath applicator
US4863449A (en) 1987-07-06 1989-09-05 Hollister Incorporated Adhesive-lined elastic condom cathether
US4872450A (en) 1984-08-17 1989-10-10 Austad Eric D Wound dressing and method of forming same
US4878901A (en) 1986-10-10 1989-11-07 Sachse Hans Ernst Condom catheter, a urethral catheter for the prevention of ascending infections
GB2220357A (en) 1988-05-28 1990-01-10 Smiths Industries Plc Medico-surgical containers
US4897081A (en) 1984-05-25 1990-01-30 Thermedics Inc. Percutaneous access device
US4906233A (en) 1986-05-29 1990-03-06 Terumo Kabushiki Kaisha Method of securing a catheter body to a human skin surface
US4906240A (en) 1988-02-01 1990-03-06 Matrix Medica, Inc. Adhesive-faced porous absorbent sheet and method of making same
US4919654A (en) 1988-08-03 1990-04-24 Kalt Medical Corporation IV clamp with membrane
CA2005436A1 (en) 1988-12-13 1990-06-13 Glenda G. Kalt Transparent tracheostomy tube dressing
US4941882A (en) 1987-03-14 1990-07-17 Smith And Nephew Associated Companies, P.L.C. Adhesive dressing for retaining a cannula on the skin
US4953565A (en) 1986-11-26 1990-09-04 Shunro Tachibana Endermic application kits for external medicines
US4969880A (en) 1989-04-03 1990-11-13 Zamierowski David S Wound dressing and treatment method
US4985019A (en) 1988-03-11 1991-01-15 Michelson Gary K X-ray marker
GB2235877A (en) 1989-09-18 1991-03-20 Antonio Talluri Closed wound suction apparatus
US5037397A (en) 1985-05-03 1991-08-06 Medical Distributors, Inc. Universal clamp
US5086170A (en) 1989-01-16 1992-02-04 Roussel Uclaf Process for the preparation of azabicyclo compounds
US5092858A (en) 1990-03-20 1992-03-03 Becton, Dickinson And Company Liquid gelling agent distributor device
US5100396A (en) 1989-04-03 1992-03-31 Zamierowski David S Fluidic connection system and method
US5134994A (en) 1990-02-12 1992-08-04 Say Sam L Field aspirator in a soft pack with externally mounted container
US5149331A (en) 1991-05-03 1992-09-22 Ariel Ferdman Method and device for wound closure
US5167613A (en) 1992-03-23 1992-12-01 The Kendall Company Composite vented wound dressing
US5176663A (en) 1987-12-02 1993-01-05 Pal Svedman Dressing having pad with compressibility limiting elements
US5215522A (en) 1984-07-23 1993-06-01 Ballard Medical Products Single use medical aspirating device and method
US5232453A (en) 1989-07-14 1993-08-03 E. R. Squibb & Sons, Inc. Catheter holder
US5261893A (en) 1989-04-03 1993-11-16 Zamierowski David S Fastening system and method
US5278100A (en) 1991-11-08 1994-01-11 Micron Technology, Inc. Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers
US5279550A (en) 1991-12-19 1994-01-18 Gish Biomedical, Inc. Orthopedic autotransfusion system
US5298015A (en) 1989-07-11 1994-03-29 Nippon Zeon Co., Ltd. Wound dressing having a porous structure
US5342376A (en) 1993-05-03 1994-08-30 Dermagraphics, Inc. Inserting device for a barbed tissue connector
US5344415A (en) 1993-06-15 1994-09-06 Deroyal Industries, Inc. Sterile system for dressing vascular access site
DE4306478A1 (en) 1993-03-02 1994-09-08 Wolfgang Dr Wagner Drainage device, in particular pleural drainage device, and drainage method
US5358494A (en) 1989-07-11 1994-10-25 Svedman Paul Irrigation dressing
US5437651A (en) 1993-09-01 1995-08-01 Research Medical, Inc. Medical suction apparatus
US5437622A (en) 1992-04-29 1995-08-01 Laboratoire Hydrex (Sa) Transparent adhesive dressing with reinforced starter cuts
DE29504378U1 (en) 1995-03-15 1995-09-14 Mtg Medizinisch Tech Geraeteba Electronically controlled low-vacuum pump for chest and wound drainage
US5527293A (en) 1989-04-03 1996-06-18 Kinetic Concepts, Inc. Fastening system and method
US5549584A (en) 1994-02-14 1996-08-27 The Kendall Company Apparatus for removing fluid from a wound
US5556375A (en) 1994-06-16 1996-09-17 Hercules Incorporated Wound dressing having a fenestrated base layer
US5607388A (en) 1994-06-16 1997-03-04 Hercules Incorporated Multi-purpose wound dressing
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US5645081A (en) 1991-11-14 1997-07-08 Wake Forest University Method of treating tissue damage and apparatus for same
US5749843A (en) * 1989-02-25 1998-05-12 Smith & Nephew Group Research Centre Woven or knitted elastic bandages having controlled compressive forces
GB2333965A (en) 1997-09-12 1999-08-11 Kci Medical Ltd Surgical drape
US6071267A (en) 1998-02-06 2000-06-06 Kinetic Concepts, Inc. Medical patient fluid management interface system and method
US6135116A (en) 1997-07-28 2000-10-24 Kci Licensing, Inc. Therapeutic method for treating ulcers
US6241747B1 (en) 1993-05-03 2001-06-05 Quill Medical, Inc. Barbed Bodily tissue connector
US6287316B1 (en) 1999-03-26 2001-09-11 Ethicon, Inc. Knitted surgical mesh
US20020077661A1 (en) 2000-12-20 2002-06-20 Vahid Saadat Multi-barbed device for retaining tissue in apposition and methods of use
US20020115951A1 (en) 2001-02-22 2002-08-22 Core Products International, Inc. Ankle brace providing upper and lower ankle adjustment
US20020120185A1 (en) 2000-05-26 2002-08-29 Kci Licensing, Inc. System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure
US20020143286A1 (en) 2001-03-05 2002-10-03 Kci Licensing, Inc. Vacuum assisted wound treatment apparatus and infection identification system and method
US6488643B1 (en) 1998-10-08 2002-12-03 Kci Licensing, Inc. Wound healing foot wrap
US6493568B1 (en) 1994-07-19 2002-12-10 Kci Licensing, Inc. Patient interface system
AU755496B2 (en) 1997-09-12 2002-12-12 Kci Licensing, Inc. Surgical drape and suction head for wound treatment
US20040162512A1 (en) * 2003-02-19 2004-08-19 3M Innovative Properties Company Conformable wound dressing
US20050131327A1 (en) 2000-11-29 2005-06-16 Lockwood Jeffrey S. Vacuum therapy and cleansing dressing for wounds
WO2005105174A1 (en) 2004-04-27 2005-11-10 Smith & Nephew, Plc Wound cleansing apparatus with stress
US20060079852A1 (en) 2002-12-31 2006-04-13 Bubb Stephen K Externally-applied patient interface system and method
US20070185426A1 (en) 2001-02-16 2007-08-09 Kci Licensing, Inc. Biocompatible wound dressing
JP4129536B2 (en) 2000-02-24 2008-08-06 ヴェネテック インターナショナル,インコーポレイテッド Highly compatible catheter anchoring system
US20100049151A1 (en) * 2006-11-30 2010-02-25 Medela Holding Ag Device for Treating Wounds
US7709021B2 (en) * 2002-04-26 2010-05-04 Lohmann & Rauscher Gmbh Microbial cellulose wound dressing for treating chronic wounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4266545A (en) 1979-04-06 1981-05-12 Moss James P Portable suction device for collecting fluids from a closed wound
WO1987004626A1 (en) 1986-01-31 1987-08-13 Osmond, Roger, L., W. Suction system for wound and gastro-intestinal drainage
GB8906100D0 (en) 1989-03-16 1989-04-26 Smith & Nephew Laminates
US5377715A (en) * 1992-11-09 1995-01-03 Andenmatten; Roy W. Method for eliminating hazardous materials from cargo tank wet lines
EP0853950B1 (en) 1994-08-22 2002-10-30 Kinetic Concepts, Inc. Wound drainage canister
GB9523253D0 (en) 1995-11-14 1996-01-17 Mediscus Prod Ltd Portable wound treatment apparatus
US7651507B2 (en) * 2003-03-03 2010-01-26 Kci Licensing, Inc. Tissue processing system
US20030023196A1 (en) * 2001-07-24 2003-01-30 Jim Liguori Shrink wrap bandage
US7683234B2 (en) * 2006-08-03 2010-03-23 The Board Of Trustees Of The Leland Stanford Junior University Devices and bandages for the treatment or prevention of scars and/or keloids and methods and kits therefor
GB0518826D0 (en) * 2005-09-15 2005-10-26 Smith & Nephew Apparatus with actives from tissue - exudialysis
US20070185463A1 (en) * 2006-02-07 2007-08-09 Tyco Heal Thcare Group Lp Surgical wound dressing
AU2007300111B2 (en) * 2006-09-26 2013-10-24 T.J. Smith & Nephew, Limited Lattice dressing
CA2669039A1 (en) 2006-11-30 2008-06-05 Medela Holding Ag Device for treating wounds
CN101605519B (en) * 2007-02-09 2013-05-22 凯希特许有限公司 Breathable interface system for topical pressure reducing
RU2440150C2 (en) * 2007-02-20 2012-01-20 КейСиАй Лайсензинг Инк. System and method of differentiating state of leak and state of reservoir disconnection in system of processing with lower pressure
US8246590B2 (en) 2007-10-11 2012-08-21 Spiracur, Inc. Closed incision negative pressure wound therapy device and methods of use

Patent Citations (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1355846A (en) 1920-02-06 1920-10-19 David A Rannells Medical appliance
US2012755A (en) * 1934-07-12 1935-08-27 Muth Otto De Surgical dressing
US2547758A (en) 1949-01-05 1951-04-03 Wilmer B Keeling Instrument for treating the male urethra
US2632443A (en) 1949-04-18 1953-03-24 Eleanor P Lesher Surgical dressing
GB692578A (en) 1949-09-13 1953-06-10 Minnesota Mining & Mfg Improvements in or relating to drape sheets for surgical use
US2682873A (en) 1952-07-30 1954-07-06 Johnson & Johnson General purpose protective dressing
US2910763A (en) 1955-08-17 1959-11-03 Du Pont Felt-like products
US2969057A (en) 1957-11-04 1961-01-24 Brady Co W H Nematodic swab
US3066672A (en) 1960-09-27 1962-12-04 Jr William H Crosby Method and apparatus for serial sampling of intestinal juice
US3367332A (en) 1965-08-27 1968-02-06 Gen Electric Product and process for establishing a sterile area of skin
US3520300A (en) 1967-03-15 1970-07-14 Amp Inc Surgical sponge and suction device
US3568675A (en) 1968-08-30 1971-03-09 Clyde B Harvey Fistula and penetrating wound dressing
US3682180A (en) 1970-06-08 1972-08-08 Coilform Co Inc Drain clip for surgical drain
US3648692A (en) 1970-12-07 1972-03-14 Parke Davis & Co Medical-surgical dressing for burns and the like
US3826254A (en) 1973-02-26 1974-07-30 Verco Ind Needle or catheter retaining appliance
US4096853A (en) 1975-06-21 1978-06-27 Hoechst Aktiengesellschaft Device for the introduction of contrast medium into an anus praeter
DE2640413A1 (en) 1976-09-08 1978-03-09 Wolf Gmbh Richard CATHETER MONITORING DEVICE
US4245630A (en) 1976-10-08 1981-01-20 T. J. Smith & Nephew, Ltd. Tearable composite strip of materials
US4233969A (en) 1976-11-11 1980-11-18 Lock Peter M Wound dressing materials
US4080970A (en) 1976-11-17 1978-03-28 Miller Thomas J Post-operative combination dressing and internal drain tube with external shield and tube connector
US4139004A (en) 1977-02-17 1979-02-13 Gonzalez Jr Harry Bandage apparatus for treating burns
US4184510A (en) 1977-03-15 1980-01-22 Fibra-Sonics, Inc. Valued device for controlling vacuum in surgery
US4165748A (en) 1977-11-07 1979-08-28 Johnson Melissa C Catheter tube holder
US4256109A (en) 1978-07-10 1981-03-17 Nichols Robert L Shut off valve for medical suction apparatus
US4275721A (en) 1978-11-28 1981-06-30 Landstingens Inkopscentral Lic, Ekonomisk Forening Vein catheter bandage
US4382441A (en) 1978-12-06 1983-05-10 Svedman Paul Device for treating tissues, for example skin
US4284079A (en) 1979-06-28 1981-08-18 Adair Edwin Lloyd Method for applying a male incontinence device
US4261363A (en) 1979-11-09 1981-04-14 C. R. Bard, Inc. Retention clips for body fluid drains
US4569348A (en) 1980-02-22 1986-02-11 Velcro Usa Inc. Catheter tube holder strap
US4480638A (en) 1980-03-11 1984-11-06 Eduard Schmid Cushion for holding an element of grafted skin
US4297995A (en) 1980-06-03 1981-11-03 Key Pharmaceuticals, Inc. Bandage containing attachment post
US4333468A (en) 1980-08-18 1982-06-08 Geist Robert W Mesentery tube holder apparatus
US4465485A (en) 1981-03-06 1984-08-14 Becton, Dickinson And Company Suction canister with unitary shut-off valve and filter features
US4392853A (en) 1981-03-16 1983-07-12 Rudolph Muto Sterile assembly for protecting and fastening an indwelling device
US4373519A (en) 1981-06-26 1983-02-15 Minnesota Mining And Manufacturing Company Composite wound dressing
US4392858A (en) 1981-07-16 1983-07-12 Sherwood Medical Company Wound drainage device
US4419097A (en) 1981-07-31 1983-12-06 Rexar Industries, Inc. Attachment for catheter tube
AU550575B2 (en) 1981-08-07 1986-03-27 Richard Christian Wright Wound drainage device
US4608041A (en) 1981-10-14 1986-08-26 Frese Nielsen Device for treatment of wounds in body tissue of patients by exposure to jets of gas
US4525166A (en) 1981-11-21 1985-06-25 Intermedicat Gmbh Rolled flexible medical suction drainage device
US4551139A (en) 1982-02-08 1985-11-05 Marion Laboratories, Inc. Method and apparatus for burn wound treatment
US4475909A (en) 1982-05-06 1984-10-09 Eisenberg Melvin I Male urinary device and method for applying the device
EP0100148A1 (en) 1982-07-06 1984-02-08 Dow Corning Limited Medical-surgical dressing and a process for the production thereof
EP0117632A2 (en) 1983-01-27 1984-09-05 Johnson & Johnson Products Inc. Adhesive film dressing
US4548202A (en) 1983-06-20 1985-10-22 Ethicon, Inc. Mesh tissue fasteners
US4540412A (en) 1983-07-14 1985-09-10 The Kendall Company Device for moist heat therapy
US4543100A (en) 1983-11-01 1985-09-24 Brodsky Stuart A Catheter and drain tube retainer
US4525374A (en) 1984-02-27 1985-06-25 Manresa, Inc. Treating hydrophobic filters to render them hydrophilic
EP0161865A2 (en) 1984-05-03 1985-11-21 Smith and Nephew Associated Companies p.l.c. Adhesive wound dressing
US4897081A (en) 1984-05-25 1990-01-30 Thermedics Inc. Percutaneous access device
US5215522A (en) 1984-07-23 1993-06-01 Ballard Medical Products Single use medical aspirating device and method
US4664662A (en) 1984-08-02 1987-05-12 Smith And Nephew Associated Companies Plc Wound dressing
US4872450A (en) 1984-08-17 1989-10-10 Austad Eric D Wound dressing and method of forming same
US4655754A (en) 1984-11-09 1987-04-07 Stryker Corporation Vacuum wound drainage system and lipids baffle therefor
US4826494A (en) 1984-11-09 1989-05-02 Stryker Corporation Vacuum wound drainage system
US4605399A (en) 1984-12-04 1986-08-12 Complex, Inc. Transdermal infusion device
US5037397A (en) 1985-05-03 1991-08-06 Medical Distributors, Inc. Universal clamp
US4640688A (en) 1985-08-23 1987-02-03 Mentor Corporation Urine collection catheter
US4710165A (en) 1985-09-16 1987-12-01 Mcneil Charles B Wearable, variable rate suction/collection device
US4758220A (en) 1985-09-26 1988-07-19 Alcon Laboratories, Inc. Surgical cassette proximity sensing and latching apparatus
US4733659A (en) 1986-01-17 1988-03-29 Seton Company Foam bandage
US4838883A (en) 1986-03-07 1989-06-13 Nissho Corporation Urine-collecting device
US4906233A (en) 1986-05-29 1990-03-06 Terumo Kabushiki Kaisha Method of securing a catheter body to a human skin surface
US4840187A (en) 1986-09-11 1989-06-20 Bard Limited Sheath applicator
GB2195255A (en) 1986-09-30 1988-04-07 Vacutec Uk Limited Method and apparatus for vacuum treatment of an epidermal surface
US4743232A (en) 1986-10-06 1988-05-10 The Clinipad Corporation Package assembly for plastic film bandage
US4878901A (en) 1986-10-10 1989-11-07 Sachse Hans Ernst Condom catheter, a urethral catheter for the prevention of ascending infections
US4953565A (en) 1986-11-26 1990-09-04 Shunro Tachibana Endermic application kits for external medicines
GB2197789A (en) 1986-11-28 1988-06-02 Smiths Industries Plc Anti-foaming disinfectants used in surgical suction apparatus
US4941882A (en) 1987-03-14 1990-07-17 Smith And Nephew Associated Companies, P.L.C. Adhesive dressing for retaining a cannula on the skin
US4787888A (en) 1987-06-01 1988-11-29 University Of Connecticut Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a)
US4863449A (en) 1987-07-06 1989-09-05 Hollister Incorporated Adhesive-lined elastic condom cathether
US5176663A (en) 1987-12-02 1993-01-05 Pal Svedman Dressing having pad with compressibility limiting elements
US4906240A (en) 1988-02-01 1990-03-06 Matrix Medica, Inc. Adhesive-faced porous absorbent sheet and method of making same
US4985019A (en) 1988-03-11 1991-01-15 Michelson Gary K X-ray marker
GB2220357A (en) 1988-05-28 1990-01-10 Smiths Industries Plc Medico-surgical containers
EP0358302A2 (en) 1988-05-28 1990-03-14 Smiths Industries Public Limited Company Medico-surgical suction container
US4919654A (en) 1988-08-03 1990-04-24 Kalt Medical Corporation IV clamp with membrane
CA2005436A1 (en) 1988-12-13 1990-06-13 Glenda G. Kalt Transparent tracheostomy tube dressing
US5086170A (en) 1989-01-16 1992-02-04 Roussel Uclaf Process for the preparation of azabicyclo compounds
US5749843A (en) * 1989-02-25 1998-05-12 Smith & Nephew Group Research Centre Woven or knitted elastic bandages having controlled compressive forces
US5527293A (en) 1989-04-03 1996-06-18 Kinetic Concepts, Inc. Fastening system and method
US5100396A (en) 1989-04-03 1992-03-31 Zamierowski David S Fluidic connection system and method
US4969880A (en) 1989-04-03 1990-11-13 Zamierowski David S Wound dressing and treatment method
US5261893A (en) 1989-04-03 1993-11-16 Zamierowski David S Fastening system and method
US5358494A (en) 1989-07-11 1994-10-25 Svedman Paul Irrigation dressing
US5298015A (en) 1989-07-11 1994-03-29 Nippon Zeon Co., Ltd. Wound dressing having a porous structure
US5232453A (en) 1989-07-14 1993-08-03 E. R. Squibb & Sons, Inc. Catheter holder
GB2235877A (en) 1989-09-18 1991-03-20 Antonio Talluri Closed wound suction apparatus
US5134994A (en) 1990-02-12 1992-08-04 Say Sam L Field aspirator in a soft pack with externally mounted container
US5092858A (en) 1990-03-20 1992-03-03 Becton, Dickinson And Company Liquid gelling agent distributor device
US5149331A (en) 1991-05-03 1992-09-22 Ariel Ferdman Method and device for wound closure
US5278100A (en) 1991-11-08 1994-01-11 Micron Technology, Inc. Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US5645081A (en) 1991-11-14 1997-07-08 Wake Forest University Method of treating tissue damage and apparatus for same
US5279550A (en) 1991-12-19 1994-01-18 Gish Biomedical, Inc. Orthopedic autotransfusion system
US5167613A (en) 1992-03-23 1992-12-01 The Kendall Company Composite vented wound dressing
US5437622A (en) 1992-04-29 1995-08-01 Laboratoire Hydrex (Sa) Transparent adhesive dressing with reinforced starter cuts
DE4306478A1 (en) 1993-03-02 1994-09-08 Wolfgang Dr Wagner Drainage device, in particular pleural drainage device, and drainage method
US5342376A (en) 1993-05-03 1994-08-30 Dermagraphics, Inc. Inserting device for a barbed tissue connector
US6241747B1 (en) 1993-05-03 2001-06-05 Quill Medical, Inc. Barbed Bodily tissue connector
US5344415A (en) 1993-06-15 1994-09-06 Deroyal Industries, Inc. Sterile system for dressing vascular access site
US5437651A (en) 1993-09-01 1995-08-01 Research Medical, Inc. Medical suction apparatus
US5549584A (en) 1994-02-14 1996-08-27 The Kendall Company Apparatus for removing fluid from a wound
US5556375A (en) 1994-06-16 1996-09-17 Hercules Incorporated Wound dressing having a fenestrated base layer
US5607388A (en) 1994-06-16 1997-03-04 Hercules Incorporated Multi-purpose wound dressing
US6493568B1 (en) 1994-07-19 2002-12-10 Kci Licensing, Inc. Patient interface system
DE29504378U1 (en) 1995-03-15 1995-09-14 Mtg Medizinisch Tech Geraeteba Electronically controlled low-vacuum pump for chest and wound drainage
US6135116A (en) 1997-07-28 2000-10-24 Kci Licensing, Inc. Therapeutic method for treating ulcers
AU745271B2 (en) 1997-09-12 2002-03-14 Kci Licensing, Inc. Surgical drape and suction head for wound treatment
GB2329127B (en) 1997-09-12 2000-08-16 Kci Medical Ltd Surgical drape and suction head for wound treatment
US6345623B1 (en) 1997-09-12 2002-02-12 Keith Patrick Heaton Surgical drape and suction head for wound treatment
GB2333965A (en) 1997-09-12 1999-08-11 Kci Medical Ltd Surgical drape
US6814079B2 (en) 1997-09-12 2004-11-09 Kci Licensing, Inc. Surgical drape and suction head for wound treatment
EP1018967B1 (en) 1997-09-12 2004-08-18 KCI Licensing, Inc. Suction head for wound treatment and combination with a surgical drape
US6553998B2 (en) 1997-09-12 2003-04-29 Kci Licensing, Inc. Surgical drape and suction head for wound treatment
AU755496B2 (en) 1997-09-12 2002-12-12 Kci Licensing, Inc. Surgical drape and suction head for wound treatment
US6071267A (en) 1998-02-06 2000-06-06 Kinetic Concepts, Inc. Medical patient fluid management interface system and method
US6488643B1 (en) 1998-10-08 2002-12-03 Kci Licensing, Inc. Wound healing foot wrap
US6287316B1 (en) 1999-03-26 2001-09-11 Ethicon, Inc. Knitted surgical mesh
JP4129536B2 (en) 2000-02-24 2008-08-06 ヴェネテック インターナショナル,インコーポレイテッド Highly compatible catheter anchoring system
US20020120185A1 (en) 2000-05-26 2002-08-29 Kci Licensing, Inc. System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure
US20050131327A1 (en) 2000-11-29 2005-06-16 Lockwood Jeffrey S. Vacuum therapy and cleansing dressing for wounds
US20020077661A1 (en) 2000-12-20 2002-06-20 Vahid Saadat Multi-barbed device for retaining tissue in apposition and methods of use
US20070185426A1 (en) 2001-02-16 2007-08-09 Kci Licensing, Inc. Biocompatible wound dressing
US20020115951A1 (en) 2001-02-22 2002-08-22 Core Products International, Inc. Ankle brace providing upper and lower ankle adjustment
US20020143286A1 (en) 2001-03-05 2002-10-03 Kci Licensing, Inc. Vacuum assisted wound treatment apparatus and infection identification system and method
US7709021B2 (en) * 2002-04-26 2010-05-04 Lohmann & Rauscher Gmbh Microbial cellulose wound dressing for treating chronic wounds
US20060079852A1 (en) 2002-12-31 2006-04-13 Bubb Stephen K Externally-applied patient interface system and method
US20040162512A1 (en) * 2003-02-19 2004-08-19 3M Innovative Properties Company Conformable wound dressing
WO2005105174A1 (en) 2004-04-27 2005-11-10 Smith & Nephew, Plc Wound cleansing apparatus with stress
US20100049151A1 (en) * 2006-11-30 2010-02-25 Medela Holding Ag Device for Treating Wounds

Non-Patent Citations (43)

* Cited by examiner, † Cited by third party
Title
A.A. Safronov, Dissertation Abstract, Vacuum Therapy of Trophic Ulcers of the Lower Leg with Simultaneous Autoplasty of the Skin (Central Scientific Research Institute of Traumatology and Orthopedics, Moscow, U.S.S.R. 1967) (certified translation).
Arnljots, Björn et al.: "Irrigation Treatment in Split-Thickness Skin Grafting of Intractable Leg Ulcers", Scand J. Plast Reconstr. Surg., No. 19, 1985, pp. 211-213.
C.E. Tennants, "The Use of Hypermia in the Postoperative Treatment of Lesions of the Extremities and Thorax," Journal of the American Medical Association 64 (1915), pp. 1548-1549.
Chariker, Mark E., M.D., et al; "Effective Management of incisional and cutaneous fistulae with closed suction wound drainage"; Contemporary Surgery, vol. 34, Jun. 1989, pp. 59-63.
Chinn, Steven D. et al.: "Closed Wound Suction Drainage", The Journal of Foot Surgery, vol. 24, No. 1, 1985, pp. 76-81.
Collins English Dictionary-Complete and Unabridged © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003. *
D.E. Tribble, An Improved Sump Drain-Irrigation Device of Simple Construction, Archives of Surgery 105 (1972) pp. 511-513.
Dattilo, Philip P., Jr., et al; "Medical Textiles: Application of an Absorbable Barbed Bi-directional Surgical Suture"; Journal of Textile and Apparel, Technology and Management, vol. 2, Issue 2, Spring 2002, pp. 1-5.
Davydov, Yu. A., et al; "Bacteriological and Cytological Assessment of Vacuum Therapy for Purulent Wounds"; Vestnik Khirurgi, Oct. 1988, pp. 48-52, and 8 page English translation thereof.
Davydov, Yu. A., et al; "Concepts for the Clinical-Biological Management of the Wound Process in the Treatment of Purulent Wounds by Means of Vacuum Therapy"; Vestnik Khirurgi, Jul. 7, 1980, pp. 132-136, and 8 page English translation thereof.
Davydov, Yu. A., et al; "Vacuum Therapy in the Treatment of Purulent Lactation Mastitis"; Vestnik Khirurgi, May 14, 1986, pp. 66-70, and 9 page English translation thereof.
Egnell Minor, Instruction Book, First Edition 300 7502, Feb. 1975, pp. 24.
Egnell Minor: Addition to the Users Manual Concerning Overflow Protection-Concerns all Egnell Pumps, Feb. 3, 1983, pp. 2.
F.E. Johnson, "An Improved Technique for Skin Graft Placement Using a Suction Drain," Surgery, Gynecology, and Obstetrics 159 (1984), pp. 584-585.
G. {hacek over (Z)}ivadinovic, V. ukic, {hacek over (Z)}. Maksimovic, . Radak, and P. Pe{hacek over (s)}ka, "Vacuum Therapy in the Treatment of Peripheral Blood Vessels," Timok Medical Journal 11 (1986), pp. 161-164 (certified translation).
G. {hacek over (Z)}ivadinović, V. ukić, {hacek over (Z)}. Maksimović, . Radak, and P. Pe{hacek over (s)}ka, "Vacuum Therapy in the Treatment of Peripheral Blood Vessels," Timok Medical Journal 11 (1986), pp. 161-164 (certified translation).
George V. Letsou, MD., et al; "Stimulation of Adenylate Cyclase Activity in Cultured Endothelial Cells Subjected to Cyclic Stretch"; Journal of Cardiovascular Surgery, 31, 1990, pp. 634-639.
International Search Report and Written Opinion date mailed Mar. 31, 2010; PCT Application No. PCT/US2009/062981.
International Search Report for PCT International Application PCT/GB95/01983; Nov. 23, 1995.
James H. Blackburn, II, MD, et al; "Negative-Pressure Dressings as a Bolster for Skin Grafts"; Annals of Plastic Surgery, vol. 40, No. 5, May 1998, pp. 453-457.
John Masters; "Reliable, Inexpensive and Simple Suction Dressings"; Letter to the Editor, British Journal of Plastic Surgery, 1998, vol. 51 (3), p. 267; Elsevier Science/The British Association of Plastic Surgeons, UK.
K.F. Jeter, T.E. Tintle, and M. Chariker, Managing Draining Wounds and Fistulae: "New and Established Methods," Chronic Wound Care, edited by D. Krasner (Health Management Publications, Inc., King of Prussia, PA 1990), pp. 240-246.
Kostyuchenok, B.M., et al; "Vacuum Treatment in the Surgical Management of Purulent Wounds"; Vestnik Khirurgi, Sep. 1986, pp. 18-21 and 6 page English translation thereof.
Louis C. Argenta, MD and Michael J. Morykwas, PhD; "Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Clinical Experience"; Annals of Plastic Surgery, vol. 38, No. 6, Jun. 1997; pp. 563-576.
M. Schein, R. Saadia, J.R. Jamieson, and G.A.G. Decker, "The 'Sandwich Technique' in the Management of the Open Abdomen," British Journal of Surgery 73 (1986), pp. 369-370.
M.J. Morykwas, L.C. Argenta, E.I. Shelton-Brown, and W. McGuirt, "Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies and Basic Foundation," Annals of Plastic Surgery 38 (1997), pp. 553-562 (Morykwas I).
N.A. Bagautdinov, "Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of the Soft Tissues," Current Problems in Modern Clinical Surgery Interdepartmental Collection, edited by V. Ye Volkov et al. (Chuvashia State University, Cheboksary, U.S.S.R. 1986);pp. 94-96 (certified translation).
Orringer, Jay, et al; "Management of Wounds in Patients with Complex Enterocutaneous Fistulas"; Surgery, Gynecology & Obstetrics, Jul. 1987, vol. 165, pp. 79-80.
PCT International Examination and Search Report, PCT International Application PCT/GB96/02802; Jan. 15, 1998 & Apr. 29, 1997.
PCT International Search Report for PCT International Application PCT/GB98/02713; Jan. 8, 1999.
PCT Written Opinion, PCT International Application PCT/GB96/02802; Sep. 3, 1997.
PCT Written Opinion; PCT International Application PCT/GB98/02713; Jun. 8, 1999.
S.E. Greer, et al "The Use of Subatmospheric Pressure Dressing Therapy to Close Lymphocutaneous Fistulas of the Groin" British Journal of Plastic Surgery (2000), 53, pp. 484-487.
Selections from W. Meyer and V. Schmieden, Bier's Hyperemic Treatment in Surgery, Medicine, and the Specialties: A Manual of Its Practical Application, (W.B. Saunders Co., Philadelphia, PA 1909), pp. 17-25, 44-64, 90-96, 167-170, and 210-211.
Susan Mendez-Eastmen, RN; "When Wounds Won't Heal" RN Jan. 1998, vol. 61 (1); Medical Economics Company, Inc., Montvale, NJ, USA; pp. 20-24.
Svedman, P. et al.: "A Dressing System Providing Fluid Supply and Suction Drainage Used for Continuous or Intermittent Irrigation", Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986, pp. 125-133.
Svedman, P.: "A Dressing Allowing Continuous Treatment of a Biosurface", IRCS Medical Science: Biomedical Technology, Clinical Medicine, Surgery and Transplantation, vol. 7, 1979, p. 221.
Svedman, P.: "Irrigation Treatment of Leg Ulcers", The Lancet, Sep. 3, 1983, pp. 532-534.
V.A. Kuznetsov & N.A. Bagautdinov, "Vacuum and Vacuum-Sorption Treatment of Open Septic Wounds," in II All-Union Conference on Wounds and Wound Infections: Presentation Abstracts, edited by B.M. Kostyuchenok et al. (Moscow, U.S.S.R. Oct. 28-29, 1986) pp. 91-92 ("Bagautdinov II").
V.A. Solovev et al., Guidelines, The Method of Treatment of Immature External Fistulas in the Upper Gastrointestinal Tract, editor-in-chief Prov. V.I. Parahonyak (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R. 1987) ("Solovev Guidelines").
V.A. Solovev, Dissertation Abstract, Treatment and Prevention of Suture Failures after Gastric Resection (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R. 1988) ("Solovev Abstract").
V.A.C.® Therapy Clinical Guidelines: A Reference Source for Clinicians (Jul. 2007).
Yusupov. Yu. N., et al; "Active Wound Drainage", Vestnik Khirurgi, vol. 138, Issue 4, 1987, and 7 page English translation thereof.

Cited By (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10548776B2 (en) 2006-09-26 2020-02-04 Smith & Nephew, Inc. Wound dressing
US9820888B2 (en) 2006-09-26 2017-11-21 Smith & Nephew, Inc. Wound dressing
US11701263B2 (en) 2006-09-26 2023-07-18 Smith & Nephew, Inc. Wound dressing
US10695472B2 (en) 2008-03-13 2020-06-30 Smith & Nephew Plc Vacuum closure device
US11357905B2 (en) 2008-03-13 2022-06-14 Smith & Nephew Plc Vacuum closure device
US9370450B2 (en) 2009-02-13 2016-06-21 Smith & Nephew Plc Wound packing
US10363345B2 (en) 2009-02-13 2019-07-30 Smith & Nephew Plc Wound packing
US11357903B2 (en) 2009-02-13 2022-06-14 Smith & Nephew Plc Wound packing
US9421132B2 (en) 2011-02-04 2016-08-23 University Of Massachusetts Negative pressure wound closure device
US9301742B2 (en) 2011-02-04 2016-04-05 University Of Massachusetts Negative pressure wound closure device
US9226737B2 (en) 2011-02-04 2016-01-05 University Of Massachusetts Negative pressure wound closure device
US11166726B2 (en) 2011-02-04 2021-11-09 University Of Massachusetts Negative pressure wound closure device
US10405861B2 (en) 2011-02-04 2019-09-10 University Of Massachusetts Negative pressure wound closure device
US10220125B2 (en) 2012-02-03 2019-03-05 Smith & Nephew Plc Apparatuses and methods for wound therapy
USD733896S1 (en) 2012-05-04 2015-07-07 Genadyne Biotechnologies, Inc. Abdominal dressing
US11559439B2 (en) 2012-05-22 2023-01-24 Smith & Nephew Plc Wound closure device
US10070994B2 (en) 2012-05-22 2018-09-11 Smith & Nephew Plc Apparatuses and methods for wound therapy
US9844472B2 (en) 2012-05-22 2017-12-19 Smith & Nephew Plc Wound closure device
US11123226B2 (en) 2012-05-22 2021-09-21 Smith & Nephew Plc Apparatuses and methods for wound therapy
US10702420B2 (en) 2012-05-22 2020-07-07 Smith & Nephew Plc Wound closure device
US11241337B2 (en) 2012-05-24 2022-02-08 Smith & Nephew, Inc. Devices and methods for treating and closing wounds with negative pressure
US10117782B2 (en) 2012-05-24 2018-11-06 Smith & Nephew, Inc. Devices and methods for treating and closing wounds with negative pressure
US10130520B2 (en) 2012-07-16 2018-11-20 Smith & Nephew, Inc. Negative pressure wound closure device
US9962295B2 (en) 2012-07-16 2018-05-08 Smith & Nephew, Inc. Negative pressure wound closure device
US11083631B2 (en) 2012-07-16 2021-08-10 University Of Massachusetts Negative pressure wound closure device
US11564843B2 (en) 2012-07-16 2023-01-31 University Of Massachusetts Negative pressure wound closure device
US11419767B2 (en) 2013-03-13 2022-08-23 University Of Massachusetts Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure
US10124098B2 (en) 2013-03-13 2018-11-13 Smith & Nephew, Inc. Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure
US11097044B2 (en) 2013-03-14 2021-08-24 Smith & Nephew Plc Compressible wound fillers and systems and methods of use in treating wounds with negative pressure
US10159771B2 (en) 2013-03-14 2018-12-25 Smith & Nephew Plc Compressible wound fillers and systems and methods of use in treating wounds with negative pressure
US11123474B2 (en) 2013-07-16 2021-09-21 Smith & Nephew Plc Apparatuses and methods for wound therapy
US10660992B2 (en) 2013-10-21 2020-05-26 Smith & Nephew, Inc. Negative pressure wound closure device
US10201642B2 (en) 2014-01-21 2019-02-12 Smith & Nephew Plc Collapsible dressing for negative pressure wound treatment
US11103385B2 (en) 2014-01-21 2021-08-31 Smith & Nephew Plc Wound treatment apparatuses
US11344665B2 (en) 2014-01-21 2022-05-31 Smith & Nephew Plc Collapsible dressing for negative pressure wound treatment
US10179073B2 (en) 2014-01-21 2019-01-15 Smith & Nephew Plc Wound treatment apparatuses
US10226566B2 (en) 2014-04-23 2019-03-12 Genadyne Biotechnologies, Inc. System and process for removing bodily fluids from a body opening
US10441474B1 (en) 2014-05-27 2019-10-15 Barakat Alhammadin Bandage for applying arterial pressure
US9770369B2 (en) 2014-08-08 2017-09-26 Neogenix, Llc Wound care devices, apparatus, and treatment methods
KR20160083780A (en) * 2015-01-02 2016-07-12 가톨릭관동대학교산학협력단 Medical magnet bandage
WO2016108585A1 (en) * 2015-01-02 2016-07-07 가톨릭관동대학교산학협력단 Medical magnet band
US11439539B2 (en) * 2015-04-29 2022-09-13 University Of Massachusetts Negative pressure wound closure device
US10575991B2 (en) 2015-12-15 2020-03-03 University Of Massachusetts Negative pressure wound closure devices and methods
US10814049B2 (en) 2015-12-15 2020-10-27 University Of Massachusetts Negative pressure wound closure devices and methods
US11471586B2 (en) 2015-12-15 2022-10-18 University Of Massachusetts Negative pressure wound closure devices and methods
US11135351B2 (en) 2016-08-30 2021-10-05 Smith & Nephew Plc Systems and methods for applying reduced pressure therapy
US11096832B2 (en) 2016-09-27 2021-08-24 Smith & Nephew Plc Wound closure devices with dissolvable portions
US11617684B2 (en) 2016-11-02 2023-04-04 Smith & Nephew, Inc. Wound closure devices
US11491265B2 (en) 2017-02-22 2022-11-08 Cornell University Mechanical vacuum dressing for mechanically managing, protecting and suctioning small incisional wounds
US11872110B2 (en) 2017-06-13 2024-01-16 Smith & Nephew Plc Wound closure device and method of use
US11324876B2 (en) 2017-06-13 2022-05-10 Smith & Nephew Plc Collapsible structure and method of use
US11690948B2 (en) 2017-06-14 2023-07-04 Smith & Nephew, Inc. Fluid removal management and control of wound closure in wound therapy
US11583623B2 (en) 2017-06-14 2023-02-21 Smith & Nephew Plc Collapsible structure for wound closure and method of use
US11395873B2 (en) 2017-06-14 2022-07-26 Smith & Nephew, Inc. Control of wound closure and fluid removal management in wound therapy
US11123476B2 (en) 2017-06-14 2021-09-21 Smith & Nephew, Inc. Fluid removal management and control of wound closure in wound therapy
US11724020B2 (en) 2017-06-14 2023-08-15 Smith & Nephew Plc Collapsible sheet for wound closure and method of use
US11607344B2 (en) 2017-07-27 2023-03-21 Smith & Nephew Plc Customizable wound closure device and method of use
US11590030B2 (en) 2017-08-07 2023-02-28 Smith & Nephew Plc Wound closure device with protective layer and method of use
US11375923B2 (en) 2017-08-29 2022-07-05 Smith & Nephew Plc Systems and methods for monitoring wound closure
US11839527B2 (en) 2017-12-06 2023-12-12 Cornell University Manually-operated negative pressure wound therapy (NPWT) bandage with improved pump efficiency, automatic pressure indicator and automatic pressure limiter

Also Published As

Publication number Publication date
JP5864711B2 (en) 2016-02-17
MX2011004820A (en) 2011-05-30
US20100121286A1 (en) 2010-05-13
CN102202619B (en) 2014-03-12
EP2361069A4 (en) 2017-06-21
KR20110083709A (en) 2011-07-20
BRPI0916062A2 (en) 2019-09-24
CA2742962A1 (en) 2010-05-14
AU2009311352B2 (en) 2014-06-26
EP2361069A1 (en) 2011-08-31
TW201021862A (en) 2010-06-16
CN102202619A (en) 2011-09-28
KR101644206B1 (en) 2016-08-10
AU2009311352A1 (en) 2010-05-14
EP2361069B1 (en) 2018-12-26
EP3421020A1 (en) 2019-01-02
EP3421020B1 (en) 2022-05-11
CA2742962C (en) 2018-09-25
WO2010053870A1 (en) 2010-05-14
JP2015097792A (en) 2015-05-28
JP2012508037A (en) 2012-04-05
US10398603B2 (en) 2019-09-03
US20190298577A1 (en) 2019-10-03
US20130253401A1 (en) 2013-09-26
RU2011114000A (en) 2012-12-20

Similar Documents

Publication Publication Date Title
US20190298577A1 (en) Reduced-pressure, wound-treatment dressings and systems
US8663132B2 (en) Reduced-pressure treatment systems and methods employing a variable cover
EP2285431B1 (en) Reduced-pressure surgical wound treatment systems
AU2014233596B2 (en) Reduced-pressure, wound-treatment dressings and systems

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

AS Assignment

Owner name: KCI LICENSING, INC., TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LOCKE, CHRISTOPHER BRIAN;ROBINSON, TIMOTHY MARK;SIGNING DATES FROM 20140320 TO 20140326;REEL/FRAME:032539/0945

AS Assignment

Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT, MINNESOTA

Free format text: SECOND LIEN SECURITY AGREEMENT;ASSIGNORS:KCI USA, INC.;LIFECELL CORPORATION;KCI LICENSING, INC.;REEL/FRAME:040098/0268

Effective date: 20160920

Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATE

Free format text: SECOND LIEN SECURITY AGREEMENT;ASSIGNORS:KCI USA, INC.;LIFECELL CORPORATION;KCI LICENSING, INC.;REEL/FRAME:040098/0268

Effective date: 20160920

AS Assignment

Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT, MINNESOTA

Free format text: LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNORS:KCI USA, INC.;LIFECELL CORPORATION;KCI LICENSING, INC.;REEL/FRAME:040291/0237

Effective date: 20161006

Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATE

Free format text: LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNORS:KCI USA, INC.;LIFECELL CORPORATION;KCI LICENSING, INC.;REEL/FRAME:040291/0237

Effective date: 20161006

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: KCI USA, INC., TEXAS

Free format text: RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268;ASSIGNOR:WILMINGTON TRUST;REEL/FRAME:041666/0320

Effective date: 20170203

AS Assignment

Owner name: KCI LICENSING, INC., TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:050966/0547

Effective date: 20191011

Owner name: KCI USA, INC., TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:050966/0547

Effective date: 20191011

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 8

AS Assignment

Owner name: 3M INNOVATIVE PROPERTIES COMPANY, MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KCI LICENSING, INC.;REEL/FRAME:064730/0218

Effective date: 20230824

AS Assignment

Owner name: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY, MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:3M INNOVATIVE PROPERTIES COMPANY;REEL/FRAME:066436/0063

Effective date: 20240201